RICCARDO MASETTI

Scopus Publications

Letermovir Prophylaxis Does Not Hinder Immune Reconstitution While Reshaping Viral Infection Landscape in Children
Manuela Spadea, Francesca Romani, Silvia Nucera, Alessio Tomatis, Raffaele Vitale, Viola Carzaniga, Francesco Baccelli, Alessandro Di Gangi, Francesca Dagliano, Vincenzo Apolito, Valeria Ceolin, Francesca Gottardi, Francesco Saglio, Mariacristina Menconi, Riccardo Masetti, Maura Faraci, Adriana Balduzzi, Franca Fagioli
Transplantation and Cellular Therapy, 2026
Use of Eltrombopag to Treat Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Retrospective Multicenter Study
Filomena Pierri, Francesca Bagnasco, Sara Pestarino, Francesco Saglio, Franca Fagioli, Riccardo Masetti, Davide Leardini, Maura Faraci
Transplantation and Cellular Therapy, 2026
Lymphoproliferation in inborn errors of immunity: From challenging diagnosis to histologic revision
Mattia Moratti, Beatrice Rivalta, Antonello Cardoni, Veronica Santilli, Enrico Attardi, Emma Concetta Manno, Riccardo Ciudino, Silvia Di Cesare, Cristina Cifaldi, Chiara Mengoli, Edoardo Muratore, Samuele Naviglio, Paola Selva, Simona Ferrari, Gigliola Di Matteo, Alessandro Broccoli, Nicola Cotugno, Donato Amodio, Riccardo Masetti, Elena Facchini, Pier Luigi Zinzani, Marcello Lanari, Cinzia Milito, Alberto Tommasini, Rita De Vito, Andrea Finocchi, Rita Alaggio, Elena Sabattini, Caterina Cancrini, Francesca Conti
Journal of Human Immunity, 2026
Inborn errors of immunity (IEI) are genetic disorders that not only heighten infection risk but also disrupt immune regulation, frequently leading to lymphoid tissue overgrowth known as lymphoid proliferations (LPD). We retrospectively reviewed 38 patients with genetically or clinically confirmed IEI and persistent LPD, comparing those with nonneoplastic/reactive hyperplasia to those who developed overt lymphoid neoplasm (lymphoma). Overall, 26% developed lymphoma—predominantly classical Hodgkin lymphoma or diffuse large B cell lymphoma—often after earlier IEI onset. Immunophenotyping and principal component analysis revealed that patients with common variable immunodeficiency developing Hodgkin lymphoma shared a distinctive T cell profile, differing from immunocompetent lymphoma cases. Centralized histologic re-evaluation reclassified several presumed lymphoma as nonneoplastic/reactive hyperplasia and identified Castleman-like and germinal center transformation patterns in nonneoplastic/reactive LPD. Notably, elevated blood IgM and circulating T follicular helper cells mirrored IgM deposits and PD-1+ T cells in lymph nodes. These findings highlight the importance of an integrated approach involving clinical, genetic, and pathological reviews to improve IEI diagnosis and avoid overtreatment.
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients
Davide Leardini, Marcello Roberto, Sara Roggiani, Edoardo Muratore, Marco Fabbrini, Gianluca Storci, Enrica Tomassini, Elisa Dan, Angela Schipani, Serena De Matteis, Barbara Sinigaglia, Daria Messelodi, Nicola Salvatore Bertuccio, Arcangelo Prete, Patrizia Brigidi, Francesca Bonifazi, Riccardo Masetti
Bone Marrow Transplantation, 2025
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) profoundly reshapes the gut microbiome (GM), yet age-related differences in this process remain incompletely understood. In this study, we analyzed stool samples from a cohort of pediatric and adult patients collected before allo-HSCT and at neutrophil engraftment to assess GM dynamics. We observed a significant reduction in alpha diversity post-HSCT across both age groups, with young patients displaying notably lower biodiversity. While GM composition varies among age ranges before transplantation, these distinctions largely disappeared at neutrophil engraftment, indicating a convergence toward a more uniform "transplant-specific" signature. This shift entailed a loss of health-associated, butyrate-producing taxa and a rise in potentially opportunistic bacteria (e.g., Enterococcaceae, Staphylococcaceae). Low pre-allo-HSCT GM diversity correlated with an increased risk of clinically significant acute graft-versus-host disease, overwhelming the age differences, underscoring the clinical relevance of maintaining a balanced microbiome before transplantation. Overall, our findings highlight the importance of age in shaping the pre-transplant GM and reveal how allo-HSCT-driven factors homogenize microbial communities among age ranges, offering insights for future microbiome-targeted interventions to improve transplant outcomes.
Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step Approach
Fiorentina Guida, Marianna Fabi, Anna Balducci, Daniele Zama, Riccardo Masetti, Federico Mercolini, Tamara Belotti, Maria Elena Cantarini, Elena Facchini, Elena Lara Legnani, Fraia Melchionda, Ylenia Bartolacelli, Cristina Ciuca, Valentina Gesuete, Arcangelo Prete, Andrea Donti, Marcello Lanari
Cancers, 2025
Numerous studies and international recommendations have investigated risk factors that put childhood cancer survivors (CCSs) at a higher risk of late-onset cancer therapy-related cardiovascular toxicities (CTR-CVTs). While anthracyclines and chest-directed radiotherapy are well-established high-risk treatments, other anticancer therapies, including alkylating agents, antimetabolites, targeted therapies, and hematopoietic stem cell transplantation, also carry potential cardiotoxic effects. The likelihood of developing CTR-CVT is further modulated by the presence of cardiometabolic risk factors, prior occurrence of CTR-CVT during treatment, and certain clinical conditions, which may predispose survivors to long-term cardiovascular complications. This state-of-the-art review summarizes current strategies for stratifying the risk for developing CTR-CVT in CCSs. We then propose a tailored, multimodal approach for guiding cardio-oncological assessments both during treatment and in long-term follow-up, including a structured echocardiographic protocol. Future perspectives include validation of this approach to optimize early detection and personalized management of CTR-CVT.
Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency
Lili Kotmayer, Emilia J. Kozyra, Guolian Kang, Brigitte Strahm, Ayami Yoshimi, Sushree S. Sahoo, Victor B. Pastor, Enrico Attardi, Rebecca Voss, Luca Vinci, Max Kaiser, Michael N. Dworzak, Barbara De Moerloose, Martina Sukova, Jan Starý, Henrik Hasle, Kirsi Jahnukainen, Sophia Polychronopoulou, Krisztián Kállay, Owen P. Smith, Andrea Malone, Shlomit Barzilai Birenboim, Riccardo Masetti, Jochen Buechner, Marek Ussowicz, Paula Kjöllerström, Ivana Bodova, Marko Kavcic, Albert Català, Dominik Turkiewicz, Markus Schmugge, Valerie de Haas, Victoria I. Okhomina, Cristian Sotomayor, Paula Catalán, Claudia Wehr, Ulrich Salzer, Ulrich Germing, Norbert Gattermann, Csaba Bödör, Nathan Gray, Sara Lewis, Akiko Shimamura, Alessandra Giorgetti, Miriam Erlacher, Charlotte M. Niemeyer, Marcin W. Wlodarski
Blood Cancer Journal, 2025
GATA2 deficiency is an autosomal dominant transcriptopathy disorder with high risk for myelodysplastic syndrome (MDS). To elucidate genotype-phenotype associations and identify new genetic risk factors for MDS, we analyzed 218 individuals with germline heterozygous GATA2 variants. We observed striking age-dependent incidence patterns in GATA2-related MDS (GATA2-MDS), with MDS being absent in infants, rare before age 6 years, and steeply increasing in older children. Among 108 distinct GATA2 variants (67 novel), null mutations conferred a 1.7-fold increased risk for MDS, had earlier MDS onset compared to other variants (12.2 vs. 14.6 years, p = 0.009) and were associated with lymphedema and deafness. In contrast, intron 4 variants exhibited reduced penetrance and lower risk for MDS development. Analysis of the somatic landscape revealed unique patterns of clonal hematopoiesis. SETBP1 mutations occurred exclusively in patients with monosomy 7 and their frequency decreased with age. Conversely, the frequency of STAG2 mutations and trisomy 8 increased with age and appeared protective against early development of advanced MDS. Overall, the majority (73.9%) of mutation-positive cases harbored monosomy 7, suggesting it serves as a major driver in malignant progression. Our findings provide evidence for age-appropriate surveillance, and a foundation for genotype-driven risk stratification in GATA2 deficiency.
Unmet Needs in Pediatric Oncological Patients Eligible for Palliative Care
Sara Cerasi, Davide Leardini, Claudio Chiossi, Giovanna Locatelli, Deborah Masini, Maria Prisco, Cinzia Scalera, Monica Beccaro, Riccardo Masetti, Tamara Belotti
Pediatric Blood and Cancer, 2025
The authors declare no conflicts of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Sensitivity of Pediatric Myelodysplastic Syndromes With Excess of Blasts With UBTF–TD to Venetoclax/Azacitidine
Pietro Merli, Riccardo Masetti, Martina Pigazzi, Katia Girardi, Evelina Miele, Silvia Bresolin, Francesco Baccelli, Jack H. Peplinski, Marco Becilli, Valeria Paganelli, Luisa Strocchio, Barbara Buldini, Daria Pagliara, Soheil Meshinchi, Franco Locatelli
American Journal of Hematology, 2025
UBTF-TD has been reported in a significant percentage of childhood MDS-EB and has been associated with inferior survival compared to that of patients with the wild-type gene. We treated three consecutive pediatric patients affected by UBTF-TD MDS-EB with venetoclax and azacitidine (ven/aza) in combination as 28-day cycles on a compassionate use basis three consecutive pediatric patients affected by UBTF-TD MDS-EB as a bridge to allogeneic HSCT. Treatment with ven/aza was well-tolerated, and all patients responded to the ven/aza course, achieving CR with flow-cytometry negativity. All three patients were bridged to myeloablative HSCT. All patients are disease-free and graft-versus-host disease-free at last follow-up. Comprehensive biological characterization of the disease showed (i) high expression of the BCL2 gene, paralleled by a low expression of BCL2A1 and MCL1; (ii) overexpression of both HOXA and HOXB; and (iii) a distinct methylation signature of patients with UBTF-TD myeloid neoplasms. Myelodysplastic syndromes (MDS) in children are a rare disease [1], differing from those occurring in adults in terms of incidence, genetics, disease characteristics, clinical course, and treatment approach. Regarding genetics, while many pediatric cases arise in the context of inherited bone marrow failure syndromes/familial MDS, data on somatic genetic alterations in the pediatric population are still limited. Recently, tandem duplications (TD) in exon 13 of the upstream binding transcription factor gene (UBTF) have been reported in 4% of a cohort of pediatric acute myelogenous leukemia (AML) [2], and thereafter in childhood MDS with excess of blasts (EB), where prevalence was 34% [3]. Notably, patients with UBTF-TD MDS-EB showed inferior survival compared to those with the wild-type (wt) gene [3]. This parallels UBTF-TD AML, in which response to chemotherapy is poor, resulting in a probability of overall survival (OS) of only 44% [2]. Indeed, of 25 UBTF-TD patients recently reported (19 AML and 6 MDS) and treated with chemotherapy ± allogeneic HSCT, only 11 were alive at last follow-up (2/6 with MDS), the main cause of death being relapse/progressive disease [4]. Treatment of pediatric MDS-EB is represented by HSCT, but the role of pre-transplant therapy is still a matter of debate [1]. For this reason, the European Working Group on Childhood MDS (EWOG-MDS) guidelines suggest the use of pre-transplant treatment in patients with high blast count, with schemes adapted to the individual case, with the aim of reducing blast count before HSCT. Considering the overlapping transcriptomic profile of UBTF-TD-AML with NPM1- and KMT2A-AML and the favorable response of these myeloid neoplasms to BCL-2 inhibition [5], we administered venetoclax in combination with azacytidine (ven/aza) in three children with UBTF-TD MDS-EB. Between 12/2023 and 08/2024, three consecutive children with confirmed UBTF-TD MDS-EB followed at IRCCS Bambino Gesù Children's Hospital, Rome, Italy, were treated with ven/aza. For every 28-day cycle, venetoclax was administered orally at the dose of 360 mg/m2 for 28 days, while azacitidine was given intravenously at 75 mg/m2 for 7 days (Day 1–7). Both drugs were given on an off-label basis, under the responsibility of the treating physicians. Ven/aza cycles were administered until a suitable donor was available for the transplant. Details on donors and conditioning are reported in the Supporting Information material. Adverse events were graded according to CTCAE version 5.0. Bone marrow (BM) aspirates were centralized at the laboratory of the Padova University. All DNA samples were screened for UBTF-TD by polymerase chain reaction (PCR) with specific primers previously validated (details in the Supporting Information). Allelic ratio (AR) was defined as the ratio between the area of the mutated peak and the area of the wild-type one (limit of detection 0.006). Transcriptomics and methylation analyses were performed using Illumina technologies (Illumina, CA, USA). Additionally, methylation data of UBTF-TD patients were compared to those of 843 pediatric AML samples from the Target Pediatric AML (TpAML) initiative (https://targetpediatricaml.org) to identify differentially methylated regions (DMRs) (details in the Supporting Information). Patients' characteristics (including additional genetic lesions) are reported in Table 1, while the morphology of marrow trephine [6] (before and after treatment) and the immunophenotype are reported in the Supporting Information material (Figures S1, S2, and Table S1). Two patients were treatment-naïve, while one had relapsed 1 year after a first HSCT; notably, before that HSCT, he had received two courses of intensive AML-like therapy. In this patient, UBTF-TD was not investigated at diagnosis but was identified at relapse; additionally, analysis on frozen samples identified UBTF-TD also at diagnosis. HLADR+; CD11a+; CD13+; CD33+; CD45+; CD117+ UBTF-TD CEBPA NTD mut (VAF 4%), WT1 mut (VAF 3.4%) Treatment with ven/aza was well tolerated; one patient experienced a grade 2 increase in transaminases and another an episode of grade 3 febrile neutropenia; both were considered related to treatment, but no treatment interruption was needed. Blood count kinetics of the three patients after ven/aza courses are detailed in Figure S3. All patients responded to the ven/aza course, achieving CR with flow-cytometry negativity (Figure 1). Notably, all patients achieved the best response after two cycles; one patient received a third cycle while waiting for an unrelated donor. Longitudinal molecular testing by fragment analysis showed a reduction in AR to undetectable values (Figure 1). Through scalar dilutions, we demonstrated a sensitivity up to 10−3 with this technique (Supporting Information). The concomitant disappearance of CEBPA NTD VAF and WT1 VAF in patient #1 and the reduction of KRAS VAF in patient #3 after the first ven/aza cycle were demonstrated. All three patients were bridged to HSCT, one after three cycles and the other two after two courses; conditioning was myeloablative for all of them. No major complication after transplant was recorded (except for mucositis) and all patients are disease-free and graft-versus-host disease-free at last follow-up (median value 15.9 months, range 12.4–17.9). We compared RNAseq data of the three patients with samples from: (i) non-UBTF-TD MDS-EB (n = 3), (ii) UBTF-TD AML (n = 4), (iii) AML with normal karyotype (AML-NK; n = 6), (iv) AML with KMT2A-rearrangements (AML-KMT2Ar, n = 7), and (v) AML with NUP98-rearrangements (AML-NUP98r, n = 5). We found high expression of the BCL2 gene in UBTF-TD MDS and AML, paralleled by a low expression of BCL2A1 and MCL1 (Figure S4A). Notably, while the expression of these genes was similar for MDS and AML with UBTF-TD, it differed in cases of MDS not harboring UBTF-TD. Additionally, we found overexpression of both HOXA and HOXB for both UBTF-TD MDS-EB and AML cases, while it was not detected in non-UBTF-TD MDS (Figure S4B). On PB, we observed that the mean DNA methylation level of all probes was lower in the post-therapy (0.52) than in the pre-therapy group (0.59) (p < 0.001) (details in the Supporting Information and Figure S5). Given that response to venetoclax might be modulated/enhanced by the hypomethylating agent, we studied the methylation profile of UBTF-TD and contrasted the methylation profile to patients without the variant in TpAML. Supervised clustering of the methylation data from patients with and without UBTF-TD (N = 41 vs. N = 776), revealed a distinct signature that included all patients with UBTF-TD (with substantial overlap with FLT3-ITD and WT1 mutations), demonstrating that AML with UBTF-TD have a distinct methylation profile that may contribute to response to azacytidine (Figure 2A). Surprisingly, although there is no overlap of UBTF-TD with NUP98::NSD1 fusions, all patients with NUP98::NSD1 segregated in the same methylation block. Additionally, comparison of the mutational profile of those with UBTF-TD to that in NUP98::NSD1 revealed striking similarity in genomic composition of the two variants (Figure 2B). Experimental data support the use of menin inhibitors in UBTF-TD AML [7], and a recent report showed response to revumenib, although transient, in a young adult AML UBTF-TD patient [8]. UBTF-TD and KMT2A/menin complex colocalize and interact with genomic targets to maintain leukemic stemness and proliferation. Although no study has specifically tested menin inhibitors in MDS, the frequent dysplastic features in UBTF-TD AML and the presence of UBTF-TD in a relevant percentage of pediatric MDS suggest a possible MDS-AML continuum driven by UBTF-TD [2, 9]. In our study, transcriptomic analysis indicates that MDS-EB and AML with UBTF-TD share a profile distinct from UBTF-wt MDS-EB, suggesting that UBTF-TD myeloid neoplasms could represent a unique entity. The potential of combining BCL-2 inhibition with hypomethylating agents and/or menin inhibitors is being studied in an ongoing clinical trial on NPM1/KMT2Ar/NUP98r-AML (NCT06177067). Although the treatment was chosen empirically in light of the: (i) favorable response rates of these myeloid neoplasms to BCL-2 inhibition [10], (ii) known resistance to and/or unclear clinical benefit from chemotherapy of these kinds of diseases, (iii) previous safety data [5, 11], (iv) biological rationale for BCL-2 inhibition in HOX-dysregulated UBTF-TD myeloid diseases [9, 12], and (v) synergistic effect of venetoclax with azacytidine [13], we were able to demonstrate biological correlation with the observed response. Indeed, the transcriptomic profile of the three cases was consistent with sensitivity to BCL-2 inhibition. Notably, although additional RAS mutations have been reported as conferring resistance to venetoclax [14], through increased stability and higher levels of MCL-1 protein [15], patient #3, harboring a KRAS mutation, responded well to therapy; however, contrary to what was expected in KRAS-mutated disease, he had low expression of MCL1. Additional studies from a large cohort of AML patients with UBTF-TD demonstrated a distinct methylation profile that was shared with all patients with this genetic alteration, providing rationale that hypomethylating agents may modulate/enhance response to venetoclax. Unexpected observation of co-clustering of NUP98::NSD1 AML in the same methylation block as UBTF-TD neoplasms provided rationale in investigating likelihood of response to similar therapy in patients with NUP98::NSD1 [16]. Emerging data from AML patients with NUP98::NSD1 is also suggestive of potent response to ven/aza in another very high-risk cohort of patients [16]. Although there is no co-occurrence of UBTF-TD and NUP98::NSD1, there are significant similarities between the two genomic variants, including very high enrichment of both variants in FLT3-ITD, WT1 mutations and similar outcomes. These similarities appear to extend to methylation state and response to ven/aza. In conclusion, our data indicate that UBTF-TD MDS-EB cases are biologically similar to AML cases harboring the same genetic lesion, thus further supporting the hypothesis that MDS and AML could be part of a continuum driven by UBTF-TD, and this should be considered as a separate entity. More importantly, we demonstrated, although in a small cohort, safety and efficacy of the combination of ven/aza in this population as a bridge to HSCT, which, once the control of the disease is obtained and a suitable donor is secured, should be performed rapidly. Two ven/aza treatment courses seem sufficient before transplantation; more courses can be given while waiting for the transplant (e.g., in case of unavailable donors). Finally, the same regimen could be explored in other myeloid malignancies with similar transcriptomic profiles and resistance to conventional therapies, including NUP98::NSD1 AML. Ethical approval for this case series was obtained from the local IRB. Written informed consent was obtained from parents/legal guardians. P.M. reports personal fees from Sobi, Miltenyi, and Amgen, outside the submitted work. F.L. reports personal fees from Amgen, personal fees from Novartis, other from Bellicum Pharmaceutical, other from Neovii, personal fees from Miltenyi, Medac, Jazz Pharmaceutical, and Takeda, outside the submitted work. The other authors declare no conflicts of interest. For original data, please contact [email protected]. Data S1: Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOP
Davide Leardini, Gianluca Bossù, Francesco Venturelli, Francesco Baccelli, Edoardo Muratore, Antonio Grasso, Pietro Gasperini, Chiara Pilotto, Letizia Pomponia Brescia, Nagua Giurici, Angelica Barone, Mariacristina Menconi, Elena Soncini, Daniela Onofrillo, Manuela Spadea, Francesco Fabozzi, Pietro Casartelli, Simona Rinieri, Maria Grazia Petris, Valeria Petroni, Paola Muggeo, Katia Perruccio, Cristina Meazza, Francesca Compagno, Francesco Paolo Tambaro, Maura Faraci, Angela Mastronuzzi, Riccardo Masetti, Simone Cesaro
Pediatric Blood and Cancer, 2025
BackgroundFood safety practices are widely recommended for pediatric patients with cancer or undergoing hematopoietic stem cell transplantation (HCT) to mitigate foodborne infectious risks. However, specific measures, such as the neutropenic diet (ND) or low‐microbial diet, lack robust evidence and are inconsistently implemented across pediatric hematology‐oncology centers. Additionally, data on foodborne illnesses (FBI) in this population remain scarce.ProcedureWe conducted an online survey and a retrospective review of FBI cases across 22 centers within the Italian Association of Pediatric Hematology and Oncology (AIEOP) network, 13/22 performing allogeneic HCT.ResultsAll centers provide dietary recommendations to the patients. Restrictive diets are recommended in 72% of centers during hospitalization and in 77% after discharge. Universally avoided foods include unpasteurized milk, fresh fruit without skin, moldy cheeses, bakery and ice cream products, raw eggs and derivatives, raw meat, raw or smoked fish, cured meats, shellfish, and cooked food leftovers. Fresh fruits and vegetables are commonly restricted only to patients undergoing allogeneic HCT. Ninety‐five percent of centers provide patients and their families with guidelines on cleaning food at home, including thorough cleaning of fruits and vegetables with a food disinfectant. Seven centers reported FBI cases, with eight documented cases, including two fatalities caused by meningoencephalitis related to infections from Listeria monocytogenes and Bacillus cereus, respectively.ConclusionsThis study highlights the need for standardized, evidence‐based food safety guidelines and FBI management to enhance care for pediatric patients receiving chemotherapy or HCT.
Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia
Masayuki Umeda, Ryan Lea Hiltenbrand, Nicole L Michmerhuizen, Juan M Barajas, Melvin E Thomas, Bright Arthur, Michael P Walsh, Guangchun Song, Jing J. Ma, Tamara Westover, Amit Kumar, Petri Pölönen, Cristina Mecucci, Danika Di Giacomo, Franco Locatelli, Riccardo Masetti, Salvatore Nicola Bertuccio, Martina Pigazzi, Shondra M Pruett-Miller, Stanley B Pounds, Jeffrey Rubnitz, Hiroto Inaba, Kyriakos P Papadopoulos, Michael J Wick, Ilaria Iacobucci, Charles G. Mullighan, Jeffery M Klco
Blood, 2025
Leukemias with NUP98 rearrangements exhibit heterogeneous phenotypes such as acute myeloid leukemia (AML), T-acute lymphoblastic leukemia (T-ALL), or myelodysplastic syndrome/neoplasms (MDS) associated with fusion partners, whereas the mechanism responsible for this heterogeneity is poorly understood. Through genome-wide mutational and transcriptional analyses of 177 NUP98-rearranged leukemias, we show that cooperating alterations are associated with differentiation status even among leukemias sharing the same NUP98 fusions, such as NUP98::KDM5A acute megakaryocytic leukemia (AMKL) with RB1 loss or T-ALL with NOTCH1 mutations. CUT&RUN profiling of in vitro cord blood CD34+ cell (cbCD34) models of major NUP98 fusions revealed that NUP98 fusion oncoproteins directly regulate differentiation-related genes contributing to the disease phenotypes, represented by NUP98::KDM5A binding to MEIS2 or GFI1B for megakaryocyte differentiation. In patient samples, NUP98-fusion oncoprotein binding patterns are heterogeneous, potentially shaped by somatic mutations and differentiation status. Using cbCD34 models and CRISPR/Cas9 gene editing, we show that RB1 loss cooperates with NUP98::KDM5A by blocking terminal differentiation toward platelets and expanding megakaryocyte-like cells, whereas WT1 frameshift mutations skew differentiation toward dormant lymphoid-myeloid primed progenitor cells and cycling granulocyte-monocyte progenitor cells, providing evidence for NUP98-rearranged leukemia phenotypes affected by cooperating alterations. NUP98::KDM5A cbCD34 models with RB1 or WT1 alterations have different sensitivities to menin inhibition, suggesting that cellular differentiation provides stage-specific menin dependencies and resistance mechanisms that can be leveraged for future treatment strategies for NUP98-rearranged leukemia.
Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCRαβ/CD19 depletion or post-transplant cyclophosphamide
Riccardo Masetti, Davide Leardini, Francesca Gottardi, Francesco Baccelli, Giorgio Antonio Maria Ottaviano, Francesca Vendemini, Francesco Saglio, Filomena Pierri, Mattia Algeri, Francesca Del Bufalo, Pietro Merli, Arcangelo Prete, Simone Cesaro, Marek Ussowicz, Maura Faraci, Marco Zecca, Franca Fagioli, Adriana Balduzzi, Jean‐Hugues Dalle, Franco Locatelli, Daria Pagliara
British Journal of Haematology, 2025
Biallelic SH2B3 germline variants are associated with a neonatal myeloproliferative disease and multisystemic involvement
Davide Leardini, Elisabetta Flex, Elliot Stieglitz, Sara Cerasi, Salvatore Nicola Bertuccio, Francesco Baccelli, Krisztián Kállay, Paula Kjollerstrom, Sara Batalha, Giovanna Carpentieri, Lucia Pedace, Andrea Ciolfi, Mahmoud Hammad, Maria Miranda, Marta Rojas, Anupama Rao, Andrew J. Innes, Martina Rudelius, Valeria Santini, Marco Raddi, Kok-Hoi Teh, Rita De Vito, Ayami Yoshimi, Marco Tartaglia, Franco Locatelli, Charlotte M. Niemeyer, Riccardo Masetti
European Journal of Human Genetics, 2025
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial
Federico Ravaioli, Antonio Colecchia, Jacopo Peccatori, Daria Pagliara, Anna Grassi, Francesco Barbato, Riccardo Masetti, Barbara Sarina, Simona Sica, Simone Cesaro, Chiara Nozzoli, Giovanni Manfredi Assanto, Lucia Prezioso, Stella Santarone, Francesco Saglio, Ester Vanni, Attilio Olivieri, Mario Delia, Edoardo Benedetti, Francesco Zallio, Fabrizio Pane, Cristina Skert, Mariacristina Menconi, Fabio Benedetti, Francesco De Felice, Luigi Colecchia, Tamara Belotti, Luigina Vanessa Alemanni, Margherita Ursi, Giovanni Marasco, Marcello Roberto, Amanda Vestito, Elton Dajti, Matteo Garcovich, Stefania Bramanti, Daniela Taurino, Francesco Quagliarella, Fabio Ciceri, Arcangelo Prete, Andrea Pession, Davide Festi, , Mario Arpinati, Enrico Maffini, Sadia Falcione, Rocco Maurizio Zagari, Zama Daniele, Lorenzo Lazzari, Alessandro Rambaldi, Laura Riccardi, Valentina Di Ruscio, Emilia Boccieri, Margherita Falcomer, Valsania Chiara, Virginia Vitale, Chiara Garonzi, Francesco Vizzutti, Umberto Arena, Adriano De Santis, Amelia RinaldI, Andrea Olivani, Doriana Vaddinelli, Enza Di Lembo, Manuela Spadea, Vincenzo Apolito, Dellacasa Chiara, Alessandro Busca, Giorgia Mancini, Giulio Argalia, Paola Carluccio, Francesca Passerini, Alessandro Di Gangi, Paolo Rivela, Roberto Carbone, Giorgia Battipaglia, Francesca Carobolante, Irene Franceschet, Francesca Patriarca, Michele Malagola, Riccardo Varaldo, Francesco Onida, Pavone Vincenzo, Fancesca Bonifazi, Francesca Bonifazi
Bone Marrow Transplantation, 2025
The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation
Edoardo Muratore, Giacomo Gambuti, Davide Leardini, Francesco Baccelli, Francesco Venturelli, Leyna Larcinese, Francesca Gottardi, Antonia Di Battista, Tamara Belotti, Arcangelo Prete, Riccardo Masetti
Bone Marrow Transplantation, 2025
Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths
Davide Leardini, Giacomo Gambuti, Edoardo Muratore, Francesco Baccelli, Francesca Gottardi, Francesco Venturelli, Tamara Belotti, Arcangelo Prete, Marco Fabbrini, Patrizia Brigidi, Silvia Turroni, Riccardo Masetti
Open Forum Infectious Diseases, 2025
CyberKnife in Pediatric Oncology: A Narrative Review of Treatment Approaches and Outcomes
Costanza M. Donati, Federica Medici, Arina A. Zamfir, Erika Galietta, Silvia Cammelli, Milly Buwenge, Riccardo Masetti, Arcangelo Prete, Lidia Strigari, Ludovica Forlani, Elisa D’Angelo, Alessio G. Morganti
Current Oncology, 2025
Salbutamol safety in children under 2 years of age with acute wheezing: a meta-analysis of randomised controlled trials
Luca Pierantoni, Edoardo Muratore, Sara Cerasi, Daniele Zama, Chiara Del Bono, Davide Gori, Riccardo Masetti, Marcello Lanari
Archives of Disease in Childhood, 2025
Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine
Riccardo Masetti, Gianluca Bossù, Edoardo Muratore, Davide Leardini, Milo Gatti, Riccardo Di Sario, Federico Pea, Susanna Esposito
Pediatric Drugs, 2025
Healthcare migration in Italian paediatric haematology-oncology centres belonging to AIEOP
Roberto Rondelli, Tamara Belotti, Riccardo Masetti, Franco Locatelli, Maura Massimino, Alessandra Biffi, Carlo Dufour, Franca Fagioli, Giuseppe Menna, Andrea Biondi, Claudio Favre, Marco Zecca, Nicola Santoro, Giovanna Russo, Silverio Perrotta, Andrea Pession, Arcangelo Prete
Italian Journal of Pediatrics, 2024
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
Rossana Di Staso, Beatrice Casadei, Frederick L. Locke, Michael Jain, Timothy J. Voorhees, Adam S. Kittai, Mariana Bastos-Oreiro, Antonio Gutiérrez, Alejandro Martin Garcia-Sancho, Maria Jose Terol, Monica Mead, Michael J. Maranzano, Gloria Iacoboni, Pere Barba, Mi Kwon, Rebeca Bailen, Juan Luis Reguera-Ortega, Agrima Mian, Brian Hill, Emmanuel Bachy, Franck Morschhauser, Roch Houot, Catherine Thieblemont, Steven Le Gouill, Riccardo Masetti, Davide Gori, Alessandro Broccoli, Pier Luigi Zinzani, Lisa Argnani
Blood Cancer Journal, 2024
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation
Jonathan Bohlen, Ivan Bagarić, Taja Vatovec, Masato Ogishi, Syed F. Ahmed, Axel Cederholm, Lori Buetow, Steicy Sobrino, Corentin Le Floc’h, Carlos A. Arango-Franco, Luis Seabra, Marine Michelet, Federica Barzaghi, Davide Leardini, Francesco Saettini, Francesca Vendemini, Francesco Baccelli, Albert Catala, Eleonora Gambineri, Marinella Veltroni, Yurena Aguilar de la Red, Gillian I. Rice, Filippo Consonni, Laureline Berteloot, Laetitia Largeaud, Francesca Conti, Cécile Roullion, Cécile Masson, Boris Bessot, Yoann Seeleuthner, Tom Le Voyer, Darawan Rinchai, Jérémie Rosain, Anna-Lena Neehus, Lucia Erazo-Borrás, Hailun Li, Zarah Janda, En-Jui Cho, Edoardo Muratore, Camille Soudée, Candice Lainé, Eric Delabesse, Claire Goulvestre, Cindy S. Ma, Anne Puel, Stuart G. Tangye, Isabelle André, Christine Bole-Feysot, Laurent Abel, Miriam Erlacher, Shen-Ying Zhang, Vivien Béziat, Chantal Lagresle-Peyrou, Emmanuelle Six, Marlène Pasquet, Laia Alsina, Alessandro Aiuti, Peng Zhang, Yanick J. Crow, Nils Landegren, Riccardo Masetti, Danny T. Huang, Jean-Laurent Casanova, Jacinta Bustamante
Journal of Clinical Investigation, 2024
Epilepsy after acute central nervous system complications of pediatric hematopoietic cell transplantation: A retrospective, multicenter study
Luca Bergonzini, Davide Leardini, Roberta Rao, Thomas Foiadelli, Maura Faraci, Maria Margherita Mancardi, Giulia Nobile, Alessandro Orsini, Salvatore Savasta, Francesca Gottardi, Anna Fetta, Tommaso Mina, Gabriella Casazza, Maria Cristina Menconi, Dario Pruna, Rosa Maria Mura, Antonio Piroddi, Paola Rucci, Riccardo Masetti, Duccio Maria Cordelli
Seizure, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, Kenneth J. Caldwell, Yunchao Chang, Chelsey Chen, Cheng Cheng, Zhongshan Cheng, John Choi, Valentino Conter, Kristine R. Crews, Hester A. de Groot-Kruseman, Takao Deguchi, Mariko Eguchi, Hannah E. Muhle, Sarah Elitzur, Gabriele Escherich, Burgess B. Freeman, Zhaohui Gu, Katie Han, Keizo Horibe, Toshihiko Imamura, Sima Jeha, Motohiro Kato, Kean H. Chiew, Tanya Khan, Michal Kicinski, Stefan Köhrer, Steven M. Kornblau, Rishi S. Kotecha, Chi-Kong Li, Yen-Chun Liu, Franco Locatelli, Selina M. Luger, Elisabeth M. Paietta, Atsushi Manabe, Hanne V. Marquart, Riccardo Masetti, Mellissa Maybury, Pauline Mazilier, Jules P.P. Meijerink, Sharnise Mitchell, Takako Miyamura, Andrew S. Moore, Koichi Oshima, Katarzyna Pawinska-Wasikowska, Rob Pieters, Mollie S. Prater, Shondra M. Pruett-Miller, Ching-Hon Pui, Chunxu Qu, Michaela Reiterova, Noemi Reyes, Kathryn G. Roberts, Jacob M. Rowe, Atsushi Sato, Kjeld Schmiegelow, Martin Schrappe, Shuhong Shen, Szymon Skoczeń, Orietta Spinelli, Jan Stary, Michael Svaton, Masatoshi Takagi, Junko Takita, Yanjing Tang, David T. Teachey, Paul G. Thomas, Daisuke Tomizawa, Jan Trka, Elena Varotto, Tiffaney L. Vincent, Jun J. Yang, Allen E.J. Yeoh, Yinmei Zhou, Martin Zimmermann, Hiroto Inaba, Charles G. Mullighan
Cancer Discovery, 2024
Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?
Riccardo Masetti, Francesco Baccelli, Davide Leardini, Franco Locatelli
Blood Advances, 2024
Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT
Milo Gatti, Caterina Campoli, Edoardo Muratore, Tamara Belotti, Riccardo Masetti, Marcello Lanari, Pierluigi Viale, Federico Pea
Microorganisms, 2024
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity
Rossana Di Staso, Beatrice Casadei, Marianna Gentilini, Serafina Guadagnuolo, Cinzia Pellegrini, Alessandro Broccoli, Davide Gori, Riccardo Masetti, Vittorio Stefoni, Francesca Bonifazi, Pier Luigi Zinzani, Lisa Argnani
Annals of Hematology, 2024
Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis
Francesco Baccelli, Francesca Gottardi, Edoardo Muratore, Davide Leardini, Antonio Giacomo Grasso, Davide Gori, Tamara Belotti, Arcangelo Prete, Riccardo Masetti
Bone Marrow Transplantation, 2024
Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP)
Federica Galaverna, Francesco Baccelli, Daniele Zama, Gloria Tridello, Riccardo Masetti, Elena Soncini, Rossella Mura, Federica Barzaghi, Antonella Colombini, Giulia Prunotto, Maria Rosaria D’Amico, Elisabetta Calore, Alessandra Biffi, Katia Perruccio, Pietro Gasperini, Chiara Oltolini, Francesco Quagliarella, Alice Giacomazzi, Daria Pagliara, Franco Locatelli, Simone Cesaro
Bone Marrow Transplantation, 2024
Managing the Risk of Foodborne Infections in Pediatric Patients with Cancer: Is the Neutropenic Diet Still an Option?
Laura Pedretti, Davide Leardini, Edoardo Muratore, Gaia Capoferri, Serena Massa, Sofia Rahman, Susanna Esposito, Riccardo Masetti
Nutrients, 2024
Current practices for nutritional evaluation and care during the treatment of pediatric oncology patients: a survey among AIEOP centers
Francesco Venturelli, Davide Leardini, Francesco Baccelli, Francesca Gottardi, Veronica Barat, Francesca Vendemini, Veronica Maria Folsi, Cristina Meazza, Maddalena Marinoni, Maria Ester Bernardo, Manuela Tumino, Alessandra Brugiolo, Cristina Pizzato, Laura Battisti, Patrizia Bertolini, Alessia Pancaldi, Simona Rinieri, Roberta Pericoli, Paola Coccia, Daniela Onofrillo, Francesco Fabozzi, Simona Bianchi, Daniela Rizzo, Rosa Maria Daniele, Pio Stellato, Arcangelo Prete, Riccardo Masetti, Edoardo Muratore
European Journal of Pediatrics, 2024
Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of juvenile myelomonocytic leukemia
Cristina Bugarin, Laura Antolini, Chiara Buracchi, Sergio Matarraz, Tiziana Angela Coliva, Vincent H. Van der Velden, Tomasz Szczepanski, Elaine Sobral Da Costa, Alita Van der Sluijs, Michaela Novakova, Ester Mejstrikova, Stefan Nierkens, Fabiana Vieira De Mello, Paula Fernandez, Carmen Aanei, Łukasz Sędek, Luisa Strocchio, Riccardo Masetti, Laura Sainati, Jan Philippé, Maria Grazia Valsecchi, Franco Locatelli, Jacques J.M. Van Dongen, Andrea Biondi, Alberto Orfao, Giuseppe Gaipa
Haematologica, 2024
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup
Senthilkumar Ramamoorthy, Dirk Lebrecht, Denny Schanze, Ina Schanze, Ilse Wieland, Geoffroy Andrieux, Patrick Metzger, Maria Hess, Michael H. Albert, Arndt Borkhardt, Dorine Bresters, Jochen Buechner, Albert Catala, Valerie De Haas, Michael Dworzak, Miriam Erlacher, Henrik Hasle, Kirsi Jahnukainen, Franco Locatelli, Riccardo Masetti, Jan Stary, Dominik Turkiewicz, Luca Vinci, Marcin W. Wlodarski, Ayami Yoshimi, Melanie Boerries, Charlotte M. Niemeyer, Martin Zenker, Christian Flotho
British Journal of Haematology, 2024
Author Correction: The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia (Scientific Reports, (2023), 13, 1, (6464), 10.1038/s41598-023-33094-2)
Sara Cerasi, Davide Leardini, Nunzia Lisanti, Tamara Belotti, Luca Pierantoni, Daniele Zama, Marcello Lanari, Arcangelo Prete, Riccardo Masetti
Scientific Reports, 2023
The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
Sara Cerasi, Davide Leardini, Nunzia Lisanti, Tamara Belotti, Luca Pierantoni, Daniele Zama, Marcello Lanari, Arcangelo Prete, Riccardo Masetti
Scientific Reports, 2023
Levofloxacin prophylaxis and parenteral nutrition have a detrimental effect on intestinal microbial networks in pediatric patients undergoing HSCT
Marco Fabbrini, Federica D’Amico, Davide Leardini, Edoardo Muratore, Monica Barone, Tamara Belotti, Maria Luisa Forchielli, Daniele Zama, Andrea Pession, Arcangelo Prete, Patrizia Brigidi, Simone Rampelli, Marco Candela, Silvia Turroni, Riccardo Masetti
Communications Biology, 2023
A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association
Samuele Roncareggi, Katia Girardi, Francesca Fioredda, Lucia Pedace, Luca Arcuri, Raffaele Badolato, Sonia Bonanomi, Erika Borlenghi, Emilia Cirillo, Tiziana Coliva, Filippo Consonni, Francesca Conti, Piero Farruggia, Eleonora Gambineri, Fabiola Guerra, Franco Locatelli, Gaia Mancuso, Antonio Marzollo, Riccardo Masetti, Concetta Micalizzi, Daniela Onofrillo, Matteo Piccini, Claudio Pignata, Marco Gabriele Raddi, Valeria Santini, Francesca Vendemini, Andrea Biondi, Francesco Saettini
Journal of Clinical Immunology, 2023
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children
Riccardo Masetti, Davide Leardini, Edoardo Muratore, Marco Fabbrini, Federica D'Amico, Daniele Zama, Francesco Baccelli, Francesca Gottardi, Tamara Belotti, Marek Ussowicz, Jowita Fraczkiewicz, Simone Cesaro, Marco Zecca, Pietro Merli, Marco Candela, Andrea Pession, Franco Locatelli, Arcangelo Prete, Patrizia Brigidi, Silvia Turroni
Blood, 2023
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax
Francesca Gottardi, Francesco Baccelli, Davide Leardini, Antonia Di Battista, Paolo Castellucci, Domenico D'Amico, Salvatore Serravalle, Salvatore Nicola Bertuccio, Daria Messelodi, Arcangelo Prete, Riccardo Masetti
British Journal of Haematology, 2023
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
Riccardo Masetti, Francesco Baccelli, Davide Leardini, Francesca Gottardi, Francesca Vendemini, Alessandro Di Gangi, Marco Becilli, Mariachiara Lodi, Manuela Tumino, Luca Vinci, Miriam Erlacher, Brigitte Strahm, Charlotte M. Niemeyer, Franco Locatelli
Blood Advances, 2023
Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data
Riccardo Masetti, Edoardo Muratore, Davide Gori, Arcangelo Prete, Franco Locatelli
Annals of Hematology, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A -Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group
Romy E. van Weelderen, Kim Klein, Christine J. Harrison, Yilin Jiang, Jonas Abrahamsson, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N. Dworzak, Sarah Elitzur, José M. Fernández Navarro, Robert B. Gerbing, Bianca F. Goemans, Hester A. de Groot-Kruseman, Erin Guest, Shau-Yin Ha, Henrik Hasle, Charikleia Kelaidi, Hélène Lapillonne, Guy Leverger, Franco Locatelli, Riccardo Masetti, Takako Miyamura, Ulrika Norén-Nyström, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E. Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, C. Michel Zwaan, Gertjan J.L. Kaspers
Journal of Clinical Oncology, 2023
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Luca Vinci, Christian Flotho, Peter Noellke, Dirk Lebrecht, Riccardo Masetti, Valerie de Haas, Barbara De Moerloose, Michael Dworzak, Henrik Hasle, Tayfun Güngör, Jan Starý, Dominik Turkiewicz, Marek Ussowicz, Cristina Diaz de Heredia, Jochen Buechner, Kirsi Jahnukainen, Krisztian Kallay, Ivana Bodova, Owen P. Smith, Marco Zecca, Dorine Bresters, Peter Lang, Tania Nicole Masmas, Roland Meisel, Herbert Pichler, Miriam Erlacher, Gudrun Göhring, Franco Locatelli, Brigitte Strahm, Charlotte M. Niemeyer, Ayami Yoshimi
Bone Marrow Transplantation, 2023
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system
Alice Cani, Caterina Tretti Parenzan, Chiara Frasson, Elena Rampazzo, Pamela Scarparo, Samuela Francescato, Federico Caicci, Vito Barbieri, Antonio Rosato, Simone Cesaro, Marco Zecca, Concetta Micalizzi, Laura Sainati, Martina Pigazzi, Alessandra Biffi, Barbara Buldini, Franco Locatelli, Luca Persano, Riccardo Masetti, Geertruij te Kronnie, Silvia Bresolin
Blood Advances, 2023
ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution
Francesco Baccelli, Davide Leardini, Sara Cerasi, Daria Messelodi, Salvatore Nicola Bertuccio, Riccardo Masetti
Annals of Hematology, 2023
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: An I-BFM Study Group collaboration
Anne Sofie Borg Hammer, Kristian Løvvik Juul-Dam, Julie Damgaard Sandahl, Jonas Abrahamsson, Malgorzata Czogala, Emmanuelle Delabesse, Iren Haltrich, Kirsi Jahnukainen, E. Anders Kolb, Gábor Kovács, Guy Leverger, Franco Locatelli, Riccardo Masetti, Ulrika Noren-Nyström, Susana C. Raimondi, Mareike Rasche, Dirk Reinhardt, Tomohiko Taki, Daisuke Tomizawa, Bernward Zeller, Henrik Hasle, Eigil Kjeldsen
Blood Advances, 2023
Role of Nutrition in Pediatric Patients with Cancer
Laura Pedretti, Serena Massa, Davide Leardini, Edoardo Muratore, Sofia Rahman, Andrea Pession, Susanna Esposito, Riccardo Masetti
Nutrients, 2023
Miliary leukemia cutis as extramedullary relapse of KMT2A rearranged pediatric AML
E. Muratore, T. Belotti, F. Gottardi, C. Sagramoso, A. Prete, R. Masetti
Leukemia and Lymphoma, 2023
Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
Riccardo Masetti, Edoardo Muratore, Davide Leardini, Francesco Baccelli, Andrea Pession, Arcangelo Prete, Franco Locatelli
Frontiers in Oncology, 2023
Innovative strategies to predict and prevent the risk for malnutrition in child, adolescent, and young adult cancer survivors
Fiorentina Guida, Laura Andreozzi, Daniele Zama, Arcangelo Prete, Riccardo Masetti, Marianna Fabi, Marcello Lanari
Frontiers in Nutrition, 2023
The emerging role of nutritional support in the supportive care of pediatric patients undergoing hematopoietic stem cell transplantation
Edoardo Muratore, Davide Leardini, Francesco Baccelli, Francesco Venturelli, Sara Cerasi, Andrea Zanaroli, Marcello Lanari, Arcangelo Prete, Riccardo Masetti, Daniele Zama
Frontiers in Nutrition, 2023
Treatment of steroid-refractory graft versus host disease in children
Francesca Gottardi, Davide Leardini, Edoardo Muratore, Francesco Baccelli, Sara Cerasi, Francesco Venturelli, Andrea Zanaroli, Tamara Belotti, Arcangelo Prete, Riccardo Masetti
Frontiers in Transplantation, 2023
Effectiveness of Quinolone Prophylaxis in Pediatric Acute Leukemia and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis
Davide Leardini, Edoardo Muratore, Nicoletta Abram, Francesco Baccelli, Tamara Belotti, Arcangelo Prete, Davide Gori, Riccardo Masetti
Open Forum Infectious Diseases, 2022
Transplantation to save the life, TSH screening to save the brain: A report and brief literature review of autoimmune thyroid disease after HSCT for severe combined immunodeficiency
F. Baccelli, R. Ortolano, F. Conti, E. Soncini, F. Baronio, R. Masetti, S. Ferrari, A. Cassio, A. Pession
Clinical Immunology, 2022
Pharmacomicrobiomics in Pediatric Oncology: The Complex Interplay between Commonly Used Drugs and Gut Microbiome
Davide Leardini, Francesco Venturelli, Francesco Baccelli, Sara Cerasi, Edoardo Muratore, Patrizia Brigidi, Andrea Pession, Arcangelo Prete, Riccardo Masetti
International Journal of Molecular Sciences, 2022
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants
Francesco Baccelli, Davide Leardini, Edoardo Muratore, Daria Messelodi, Salvatore Nicola Bertuccio, Maria Chiriaco, Caterina Cancrini, Francesca Conti, Fausto Castagnetti, Lucia Pedace, Andrea Pession, Ayami Yoshimi, Charlotte Niemeyer, Marco Tartaglia, Franco Locatelli, Riccardo Masetti
Human Genomics, 2022
Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the Stem Cell Transplant and the Infectious Disease Working Groups of the AIEOP network
Daniele Zama, Riccardo Masetti, Francesco Baccelli, Davide Leardini, Edoardo Muratore, Nicoletta Abram, Francesca Vendemini, Alessandra Biffi, Katia Perruccio, Maria Rosaria D’Amico, Maura Faraci, Veronica Tintori, Anita Spirito, Luca Lo Nigro, Franco Locatelli, Roberto Luksch, Francesco Saglio, Nicola Santoro, Elena Soncini, Marco Zecca, Ottavio Ziino, Arcangelo Prete, Daria Pagliara, Simone Cesaro
Bone Marrow Transplantation, 2022
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis
Riccardo Masetti, Edoardo Muratore, Davide Gori, Arcangelo Prete, Franco Locatelli
Annals of Hematology, 2022
Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients
Edoardo Muratore, Davide Leardini, Francesco Baccelli, Francesco Venturelli, Arcangelo Prete, Riccardo Masetti
Frontiers in Nutrition, 2022
Novel Insights into Fungal Infections Prophylaxis and Treatment in Pediatric Patients with Cancer
Gianluca Bossù, Riccardo Di Sario, Edoardo Muratore, Davide Leardini, Andrea Pession, Susanna Esposito, Riccardo Masetti
Antibiotics, 2022
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice during Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignancies
Milo Gatti, Caterina Campoli, Tamara Belotti, Pier Giorgio Cojutti, Riccardo Masetti, Andrea Pession, Pierluigi Viale, Federico Pea
Therapeutic Drug Monitoring, 2022
Stem Cell Transplantation in Patients Affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working Party
Simone Cesaro, Jean Donadieu, Marco Cipolli, Jean Hugues Dalle, Jan Styczynski, Riccardo Masetti, Brigitte Strahm, Margherita Mauro, Amal Alseraihy, Mahmoud Aljurf, Carlo Dufour, Regis Peffault de la Tour
Transplantation and Cellular Therapy, 2022
AML-283 The Genetic Landscape of NUP98-Rearranged Pediatric Leukemia
Masayuki Umeda, Nicole Michmerhuizen, Jing Ma, Tamara Westover, Michael P Walsh, Guangchun Song, Cristina Mecucci, Danika Di Giacomo, Franco Locatelli, Riccardo Masetti, Salvatore Nicola Bertuccio, Martina Pigazzi, Ilaria Iacobucci, Charles G Mullighan, Jeffery M Klco
Clinical Lymphoma Myeloma and Leukemia, 2022
Gluteus as a rare localization of extragonadal teratoma
Davide Leardini, Sara Cerasi, Maria Elena Cantarini, Elena Facchini, Arcangelo Prete, Riccardo Masetti
Pediatric Blood and Cancer, 2022
The Role of Nutrition in Primary and Secondary Prevention of Cardiovascular Damage in Childhood Cancer Survivors
Fiorentina Guida, Riccardo Masetti, Laura Andreozzi, Daniele Zama, Marianna Fabi, Matteo Meli, Arcangelo Prete, Marcello Lanari
Nutrients, 2022
Antimicrobial Stewardship Interventions in Pediatric Oncology: A Systematic Review
Edoardo Muratore, Francesco Baccelli, Davide Leardini, Caterina Campoli, Tamara Belotti, Pierluigi Viale, Arcangelo Prete, Andrea Pession, Riccardo Masetti, Daniele Zama
Journal of Clinical Medicine, 2022
Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies
Federica D’Amico, Nunzia Decembrino, Edoardo Muratore, Silvia Turroni, Paola Muggeo, Rosamaria Mura, Katia Perruccio, Virginia Vitale, Marco Zecca, Arcangelo Prete, Francesco Venturelli, Davide Leardini, Patrizia Brigidi, Riccardo Masetti, Simone Cesaro, Daniele Zama
Pharmaceutics, 2022
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome
Francesco Saettini, Tiziana Angela Coliva, Francesca Vendemini, Marta Galbiati, Cristina Bugarin, Riccardo Masetti, Daniele Moratto, Marco Chiarini, Fabiola Guerra, Maria Iascone, Raffaele Badolato, Giovanni Cazzaniga, Charlotte Niemeyer, Christian Flotho, Andrea Biondi
Frontiers in Pediatrics, 2022
Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement
Francesco Fabozzi, Chiara Maria Trovato, Antonella Diamanti, Angela Mastronuzzi, Marco Zecca, Serena Ilaria Tripodi, Riccardo Masetti, Davide Leardini, Edoardo Muratore, Veronica Barat, Antonella Lezo, Francesco De Lorenzo, Riccardo Caccialanza, Paolo Pedrazzoli
Cancers, 2022
GATA 2 Deficiency: Focus on Immune System Impairment
Francesco Fabozzi, Angela Mastronuzzi, Giulia Ceglie, Riccardo Masetti, Davide Leardini
Frontiers in Immunology, 2022
Febrile Neutropenia Duration Is Associated with the Severity of Gut Microbiota Dysbiosis in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Riccardo Masetti, Federica D’Amico, Daniele Zama, Davide Leardini, Edoardo Muratore, Marek Ussowicz, Jowita Fraczkiewicz, Simone Cesaro, Giulia Caddeo, Vincenza Pezzella, Tamara Belotti, Francesca Gottardi, Piero Tartari, Patrizia Brigidi, Silvia Turroni, Arcangelo Prete
Cancers, 2022
Role of CBL Mutations in Cancer and Non-Malignant Phenotype
Davide Leardini, Daria Messelodi, Edoardo Muratore, Francesco Baccelli, Salvatore N. Bertuccio, Laura Anselmi, Andrea Pession, Riccardo Masetti
Cancers, 2022
Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?
Salvatore Nicola Bertuccio, Davide Leardini, Daria Messelodi, Laura Anselmi, Francesca Manente, Federico Ragni, Salvatore Serravalle, Riccardo Masetti, Andrea Pession
Cells, 2022
Autoimmune hemolytic anemia in children with COVID-19
Daniele Zama, Livia Pancaldi, Francesco Baccelli, Fiorentina Guida, Francesca Gottardi, Nicola Dentale, Fabio Esposito, Riccardo Masetti, Pierluigi Viale, Andrea Pession
Pediatric Blood and Cancer, 2022
Chronic Constipation in Pediatrics: Pathophysiology and Diagnosis
Andrea Pession, Davide Leardini, Edoardo Muratore, Riccardo Masetti
Ano Rectal Endosonography and Manometry in Paediatrics, 2022
Treatment of Chronic Constipation in Pediatrics
Andrea Pession, Davide Leardini, Edoardo Muratore, Riccardo Masetti
Ano Rectal Endosonography and Manometry in Paediatrics, 2022
Mesial Temporal Sclerosis as Late Consequence of Posterior Reversible Encephalopathy Syndrome in Pediatric Hemato-oncologic Patients
Maura Faraci, Giulia Nobile, Lino Nobili, Riccardo Masetti, Duccio Cordelli, Francesco Toni, Stefano Giardino, Giovanni Morana, Maria M. Mancardi
Journal of Pediatric Hematology Oncology, 2022
Update on febrile neutropenia in pediatric oncological patients undergoing chemotherapy
Federica Cennamo, Riccardo Masetti, Prisca Largo, Alberto Argentiero, Andrea Pession, Susanna Esposito
Children, 2021
Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation
Riccardo Masetti, Elena Biagi, Daniele Zama, Edoardo Muratore, Federica D’Amico, Davide Leardini, Silvia Turroni, Arcangelo Prete, Patrizia Brigidi, Andrea Pession
Scientific Reports, 2021
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (Nature Medicine, (2021), 27, 10, (1806-1817), 10.1038/s41591-021-01511-6)
Sushree S. Sahoo, Victor B. Pastor, Charnise Goodings, Rebecca K. Voss, Emilia J. Kozyra, Amina Szvetnik, Peter Noellke, Michael Dworzak, Jan Starý, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Barbara De Moerloose, Albert Catala, Krisztián Kállay, Dominik Turkiewicz, Henrik Hasle, Jochen Buechner, Kirsi Jahnukainen, Marek Ussowicz, Sophia Polychronopoulou, Owen P. Smith, Oksana Fabri, Shlomit Barzilai, Valerie de Haas, Irith Baumann, Stephan Schwarz-Furlan, Jan Starý, Barbara De Moerloose, Krisztián Kallay, Owen Smith, Valérie De Haas, Gudrun Gohring, Charlotte Niemeyer, Karin Nebral, Ingrid Simonitsch-Kluppp, Pascale De Paepe, Nadine Van Roy, Vit Campr, Zuzana Zemanova, Erik Clasen-Linde, Tine Plesner, Brigitte Schlegelberger, Martina Rudelius, Kalliopi Manola, Kalliopi Stefanaki, Judit Csomor, Hajnalka Andrikovics, David Betts, Maureen O’Sullivan, Yaniv Zohar, Marta Jeison, Rita De Vito, Francesco Pasquali, Jadwiga Maldyk, Olga Haus, Helena Alaiz, Paula Kjollerstrom, Luis Mascarenhas de Lemos, Ivana Bodova, Martin Čermák, Lukas Plank, Barbara Gazic, Marko Kavcic, Helena Podgornik, Margarita Llavador Ros, Jose Cervera, Carole Gengler, Joelle Tchinda, Berna Beverloo, Roos Leguit, Marena R. Niewisch, Martin G. Sauer, Birgit Burkhardt, Peter Lang, Peter Bader, Rita Beier, Ingo Müller, Michael H. Albert, Roland Meisel, Ansgar Schulz, Gunnar Cario, Pritam K. Panda, Julius Wehrle, Shinsuke Hirabayashi, Marta Derecka, Robert Durruthy-Durruthy, Gudrun Göhring, Ayami Yoshimi-Noellke, Manching Ku, Dirk Lebrecht, Miriam Erlacher, Christian Flotho, Brigitte Strahm, Charlotte M. Niemeyer, Marcin W. Wlodarski, and
Nature Medicine, 2021
Gut microbiome in pediatric acute leukemia: From predisposition to cure
Riccardo Masetti, Edoardo Muratore, Davide Leardini, Daniele Zama, Silvia Turroni, Patrizia Brigidi, Susanna Esposito, Andrea Pession
Blood Advances, 2021
Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion
Annalisa Astolfi, Riccardo Masetti, Valentina Indio, Salvatore Nicola Bertuccio, Daria Messelodi, Simone Rampelli, Davide Leardini, Matteo Carella, Salvatore Serravalle, Virginia Libri, Jessica Bandini, Stefano Volinia, Marco Candela, Andrea Pession
Blood, 2021
Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome
Rachel Bortnick, Marcin Wlodarski, Valerie de Haas, Barbara De Moerloose, Michael Dworzak, Henrik Hasle, Riccardo Masetti, Jan Starý, Dominik Turkiewicz, Marek Ussowicz, Emilia Kozyra, Michael Albert, Peter Bader, Victoria Bordon, Gunnar Cario, Rita Beier, Johannes Schulte, Dorine Bresters, Ingo Müller, Herbert Pichler, Petr Sedlacek, Martin G. Sauer, Marco Zecca, Gudrun Göhring, Ayami Yoshimi, Peter Noellke, Miriam Erlacher, Franco Locatelli, Charlotte M. Niemeyer, Brigitte Strahm, and
Bone Marrow Transplantation, 2021
Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients — a 25-year Italian experience
Anna Maria Testi, Sara Mohamed, Daniela Diverio, Alfonso Piciocchi, Giuseppe Menna, Carmelo Rizzari, Fabio Timeus, Concetta Micalizzi, Luca Lo Nigro, Nicola Santoro, Riccardo Masetti, Maria Vittoria Micheletti, Ottavio Ziino, Daniela Onofrillo, Saverio Ladogana, Caterina Putti, Paolo Pierani, Valentina Arena, Marco Zecca, Robin Foà, Franco Locatelli
British Journal of Haematology, 2021
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Sushree S. Sahoo, Victor B. Pastor, Charnise Goodings, Rebecca K. Voss, Emilia J. Kozyra, Amina Szvetnik, Peter Noellke, Michael Dworzak, Jan Starý, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Barbara De Moerloose, Albert Catala, Krisztián Kállay, Dominik Turkiewicz, Henrik Hasle, Jochen Buechner, Kirsi Jahnukainen, Marek Ussowicz, Sophia Polychronopoulou, Owen P. Smith, Oksana Fabri, Shlomit Barzilai, Valerie de Haas, Irith Baumann, Stephan Schwarz-Furlan, Jan Starý, Barbara De Moerloose, Krisztián Kallay, Owen Smith, Valérie De Haas, Gudrun Gohring, Charlotte Niemeyer, Karin Nebral, Ingrid Simonitsch-Kluppp, Pascale De Paepe, Nadine Van Roy, Vit Campr, Zuzana Zemanova, Erik Clasen-Linde, Tine Plesner, Brigitte Schlegelberger, Martina Rudelius, Kalliopi Manola, Kalliopi Stefanaki, Judit Csomor, Hajnalka Andrikovics, David Betts, Maureen O’Sullivan, Yaniv Zohar, Marta Jeison, Rita De Vito, Francesco Pasquali, Jadwiga Maldyk, Olga Haus, Helena Alaiz, Paula Kjollerstrom, Luis Mascarenhas de Lemos, Ivana Bodova, Martin Čermák, Lukas Plank, Barbara Gazic, Marko Kavcic, Helena Podgornik, Margarita Llavador Ros, Jose Cervera, Carole Gengler, Joelle Tchinda, Berna Beverloo, Roos Leguit, Marena R. Niewisch, Martin G. Sauer, Birgit Burkhardt, Peter Lang, Peter Bader, Rita Beier, Ingo Müller, Michael H. Albert, Roland Meisel, Ansgar Schulz, Gunnar Cario, Pritam K. Panda, Julius Wehrle, Shinsuke Hirabayashi, Marta Derecka, Robert Durruthy-Durruthy, Gudrun Göhring, Ayami Yoshimi-Noellke, Manching Ku, Dirk Lebrecht, Miriam Erlacher, Christian Flotho, Brigitte Strahm, Charlotte M. Niemeyer, Marcin W. Wlodarski, and
Nature Medicine, 2021
Autoimmunity and cancer
Riccardo Masetti, Alessandra Tiri, Anna Tignanelli, Elena Turrini, Alberto Argentiero, Andrea Pession, Susanna Esposito
Autoimmunity Reviews, 2021
Potential diagnostic and prognostic biomarkers for adenovirus respiratory infection in children and young adults
Giovanni Battista Biserni, Sara Scarpini, Arianna Dondi, Carlotta Biagi, Luca Pierantoni, Riccardo Masetti, Sugitha Sureshkumar, Alessandro Rocca, Marcello Lanari
Viruses, 2021
CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript
Andrea Zangrando, Francesca Cavagnero, Pamela Scarparo, Elena Varotto, Samuela Francescato, Claudia Tregnago, Rosanna Cuccurullo, Franca Fagioli, Luca Lo Nigro, Riccardo Masetti, Maria Caterina Putti, Carmelo Rizzari, Nicola Santoro, Andrea Pession, Martina Pigazzi, Franco Locatelli, Giuseppe Basso, Barbara Buldini
Cytometry Part A, 2021
Impact of sars-cov-2 pandemic on bronchiolitis hospitalizations: The experience of an italian tertiary center
Giacomo Stera, Luca Pierantoni, Riccardo Masetti, Davide Leardini, Carlotta Biagi, Danilo Buonsenso, Andrea Pession, Marcello Lanari
Children, 2021
Necrotizing enterocolitis: Overview on in vitro models
Luigia De Fazio, Isadora Beghetti, Salvatore Nicola Bertuccio, Concetta Marsico, Silvia Martini, Riccardo Masetti, Andrea Pession, Luigi Corvaglia, Arianna Aceti
International Journal of Molecular Sciences, 2021
Exploiting clonal evolution to improve the diagnosis and treatment efficacy prediction in pediatric aml
Salvatore Nicola Bertuccio, Laura Anselmi, Riccardo Masetti, Annalisa Lonetti, Sara Cerasi, Sara Polidori, Salvatore Serravalle, Andrea Pession
Cancers, 2021
Inborn errors of immunity and cancer
Alessandra Tiri, Riccardo Masetti, Francesca Conti, Anna Tignanelli, Elena Turrini, Patrizia Bertolini, Susanna Esposito, Andrea Pession
Biology, 2021
Editorial: Recent Advances in Pediatric Cancer Predisposition Syndromes
Angela Mastronuzzi, Luigi Boccuto, Riccardo Masetti
Frontiers in Pediatrics, 2021
Computed Tomography in Acute Severe Central Nervous System Complications in Children Treated for Cancer: Still a Useful Diagnostic Tool in the Emergency Setting
Emilia Ricci, Francesco Toni, Chiara Marra, Riccardo Masetti, Sayuri Porelli, Jessica Balducci, Andrea Pession, Duccio Maria Cordelli
Journal of Child Neurology, 2021
Microbiome-derived metabolites in allogeneic hematopoietic stem cell transplantation
Riccardo Masetti, Daniele Zama, Davide Leardini, Edoardo Muratore, Silvia Turroni, Patrizia Brigidi, Andrea Pession
International Journal of Molecular Sciences, 2021
Enteral versus Parenteral Nutrition as Nutritional Support after Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-Analysis
Daniele Zama, Davide Gori, Edoardo Muratore, Davide Leardini, Flavia Rallo, Silvia Turroni, Arcangelo Prete, Patrizia Brigidi, Andrea Pession, Riccardo Masetti
Transplantation and Cellular Therapy, 2021
Fecal microbiota transplantation in allogeneic hematopoietic stem cell transplantation recipients: A systematic review
Andrea Pession, Daniele Zama, Edoardo Muratore, Davide Leardini, Davide Gori, Federica Guaraldi, Arcangelo Prete, Silvia Turroni, Patrizia Brigidi, Riccardo Masetti
Journal of Personalized Medicine, 2021
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis
F. Saettini, T. Coliva, F. Vendemini, D. Moratto, G. Savoldi, E. Borlenghi, R. Masetti, C. M. Niemeyer, A. Biondi, A. Balduzzi, S. Bonanomi
Pediatric Hematology and Oncology, 2021
Off-label use of letermovir as preemptive anti-cytomegalovirus therapy in a pediatric allogeneic peripheral blood stem cell transplant
Angela Chiereghin, Tamara Belotti, Eva Caterina Borgatti, Nicola Fraccascia, Giulia Piccirilli, Maura Fois, Michele Borghi, Gabriele Turello, Liliana Gabrielli, Riccardo Masetti, Arcangelo Prete, Stefano Fanti, Tiziana Lazzarotto
Infection and Drug Resistance, 2021
Posterior Reversible Encephalopathy Syndrome in infants and young children
Duccio Maria Cordelli, Chiara Marra, Lara Ciampoli, Davide Barbon, Francesco Toni, Daniele Zama, Lucio Giordano, Giuseppe Milito, Stefano Sartori, Laura Sainati, Thomas Foiadelli, Tommaso Mina, Lucia Fusco, Marta Santarone, Chiara Iurato, Alessandro Orsini, Giovanni Farello, Alberto Verrotti, Arianna Aceti, Riccardo Masetti
European Journal of Paediatric Neurology, 2021
Editorial: New Perspectives on Pediatric Acute Leukemia
Riccardo Masetti, Martina Pigazzi, Daniele Zama
Frontiers in Pediatrics, 2020
Immune response against adenovirus in acute upper respiratory tract infections in immunocompetent children
Giovanni Battista Biserni, Arianna Dondi, Riccardo Masetti, Jessica Bandini, Ada Dormi, Francesca Conti, Andrea Pession, Marcello Lanari
Vaccines, 2020
The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
Riccardo Masetti, Daniele Zama, Davide Leardini, Edoardo Muratore, Silvia Turroni, Arcangelo Prete, Patrizia Brigidi, Andrea Pession
Pediatric Blood and Cancer, 2020
Expanding phenotype of schimke immuno-osseous dysplasia: Congenital anomalies of the kidneys and of the urinary tract and alteration of nk cells
Cristina Bertulli, Antonio Marzollo, Margherita Doria, Silvia Di Cesare, Claudio La Scola, Francesca Mencarelli, Andrea Pasini, Maria Carmen Affinita, Enrico Vidal, Pamela Magini, Paola Dimartino, Riccardo Masetti, Laura Greco, Patrizia Palomba, Francesca Conti, Andrea Pession
International Journal of Molecular Sciences, 2020
Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children
Riccardo Masetti, Salvatore Nicola Bertuccio, Vanessa Guidi, Sara Cerasi, Annalisa Lonetti, Andrea Pession
Future Oncology, 2020
Nasal obstruction and snoring: three unusual cases as a lesson for the paediatrician
Medico E Bambino, 2020
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing
Lorena Zubovic, Silvano Piazza, Toma Tebaldi, Luca Cozzuto, Giuliana Palazzo, Viktoryia Sidarovich, Veronica De Sanctis, Roberto Bertorelli, Tim Lammens, Mattias Hofmans, Barbara De Moerloose, Julia Ponomarenko, Martina Pigazzi, Riccardo Masetti, Cristina Mecucci, Giuseppe Basso, Paolo Macchi
Journal of Hematology and Oncology, 2020
Gata2 related conditions and predisposition to pediatric myelodysplastic syndromes
Antonella Bruzzese, Davide Leardini, Riccardo Masetti, Luisa Strocchio, Katia Girardi, Mattia Algeri, Giada Del Baldo, Franco Locatelli, Angela Mastronuzzi
Cancers, 2020
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
Emilia J. Kozyra, Victor B. Pastor, Stylianos Lefkopoulos, Sushree S. Sahoo, Hauke Busch, Rebecca K. Voss, Miriam Erlacher, Dirk Lebrecht, Enikoe A. Szvetnik, Shinsuke Hirabayashi, Ramunė Pasaulienė, Lucia Pedace, Marco Tartaglia, Christian Klemann, Patrick Metzger, Melanie Boerries, Albert Catala, Henrik Hasle, Valerie de Haas, Krisztián Kállay, Riccardo Masetti, Barbara De Moerloose, Michael Dworzak, Markus Schmugge, Owen Smith, Jan Starý, Ester Mejstrikova, Marek Ussowicz, Emma Morris, Preeti Singh, Matthew Collin, Marta Derecka, Gudrun Göhring, Christian Flotho, Brigitte Strahm, Franco Locatelli, Charlotte M. Niemeyer, Eirini Trompouki, Marcin W. Wlodarski, European Working Group of MDS in Childhood (EWOG-MDS)
Leukemia, 2020
Insights on the interplay between cells metabolism and signaling: A therapeutic perspective in pediatric acute leukemias
Laura Anselmi, Salvatore Nicola Bertuccio, Annalisa Lonetti, Arcangelo Prete, Riccardo Masetti, Andrea Pession
International Journal of Molecular Sciences, 2020
Role of Vitamin D in Prevention of Food Allergy in Infants
Arianna Giannetti, Luca Bernardini, Jessica Cangemi, Marcella Gallucci, Riccardo Masetti, Giampaolo Ricci
Frontiers in Pediatrics, 2020
Presentations to the emergency department in Bologna, Italy, during COVID-19 outbreak
Riccardo Masetti, Ilaria Corsini, Davide Leardini, Marcello Lanari, Andrea Pession
BMJ Paediatrics Open, 2020
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml
Annalisa Lonetti, Valentina Indio, Maria Antonella Laginestra, Giuseppe Tarantino, Francesca Chiarini, Annalisa Astolfi, Salvatore N. Bertuccio, Alberto M. Martelli, Franco Locatelli, Andrea Pession, Riccardo Masetti
Cancers, 2020
Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children
Riccardo Masetti, Francesca Vendemini, Paola Quarello, Katia Girardi, Arcangelo Prete, Franca Fagioli, Andrea Pession, Franco Locatelli
Pediatric Blood and Cancer, 2020
Enteral nutrition protects children undergoing allogeneic hematopoietic stem cell transplantation from blood stream infections
Daniele Zama, Edoardo Muratore, Elena Biagi, Maria Luisa Forchielli, Roberto Rondelli, Marco Candela, Arcangelo Prete, Andrea Pession, Riccardo Masetti
Nutrition Journal, 2020
Occurrence of Albifimbria verrucaria in the Blood of a Female Child With Neuroblastoma
Riccardo Masetti, Antonio Prodi, Andrea Liberatore, Filomena Carfagnini, Eleonora Cappelletti, Davide Leardini, Andrea Pession, Elena De Carolis, Monica Cricca
Frontiers in Medicine, 2020
Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation
Daniele Zama, Gianluca Bossù, Davide Leardini, Edoardo Muratore, Elena Biagi, Arcangelo Prete, Andrea Pession, Riccardo Masetti
Therapeutic Advances in Hematology, 2020
The pediatric acute leukemia fusion oncogene ETO2-GLIS2 increases self-renewal and alters differentiation in a human induced pluripotent stem cells-derived model
Salvatore Nicola Bertuccio, Fabien Boudia, Marie Cambot, Cécile K. Lopez, Larissa Lordier, Alessandro Donada, Elie Robert, Cécile Thirant, Zakia Aid, Salvatore Serravalle, Annalisa Astolfi, Valentina Indio, Franco Locatelli, Andrea Pession, William Vainchenker, Riccardo Masetti, Hana Raslova, Thomas Mercher
Hemasphere, 2020
Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation
Federica D’Amico, Matteo Soverini, Daniele Zama, Clarissa Consolandi, Marco Severgnini, Arcangelo Prete, Andrea Pession, Monica Barone, Silvia Turroni, Elena Biagi, Patrizia Brigidi, Riccardo Masetti, Simone Rampelli, Marco Candela
Scientific Reports, 2019
Enteral nutrition in pediatric patients undergoing hematopoietic SCT promotes the recovery of gut microbiome homeostasis
Federica D’Amico, Elena Biagi, Simone Rampelli, Jessica Fiori, Daniele Zama, Matteo Soverini, Monica Barone, Davide Leardini, Edoardo Muratore, Arcangelo Prete, Roberto Gotti, Andrea Pession, Riccardo Masetti, Patrizia Brigidi, Silvia Turroni, Marco Candela
Nutrients, 2019
Ontogenic changes in hematopoietic hierarchy determine pediatric specificity and disease phenotype in fusion oncogene– driven myeloid leukemia
Cécile K. Lopez, Esteve Noguera, Vaia Stavropoulou, Elie Robert, Zakia Aid, Paola Ballerini, Chrystèle Bilhou-Nabera, Hélène Lapillonne, Fabien Boudia, Cécile Thirant, Alexandre Fagnan, Marie-Laure Arcangeli, Sarah J. Kinston, M'Boyba Diop, Bastien Job, Yann Lecluse, Erika Brunet, Loélia Babin, Jean Luc Villeval, Eric Delabesse, Antoine H.F.M. Peters, William Vainchenker, Muriel Gaudry, Riccardo Masetti, Franco Locatelli, Sébastien Malinge, Claus Nerlov, Nathalie Droin, Camille Lobry, Isabelle Godin, Olivier A. Bernard, Berthold Göttgens, Arnaud Petit, Françoise Pflumio, Juerg Schwaller, Thomas Mercher
Cancer Discovery, 2019
Targeted Therapies for Pediatric AML: Gaps and Perspective
Annalisa Lonetti, Andrea Pession, Riccardo Masetti
Frontiers in Pediatrics, 2019
The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children
Riccardo Masetti, Vanessa Guidi, Laura Ronchini, Nicola Salvatore Bertuccio, Franco Locatelli, Andrea Pession
Critical Reviews in Oncology Hematology, 2019
Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders
Elena Biagi, Daniele Zama, Simone Rampelli, Silvia Turroni, Patrizia Brigidi, Clarissa Consolandi, Marco Severgnini, Eleonora Picotti, Pietro Gasperini, Pietro Merli, Nunzia Decembrino, Marco Zecca, Simone Cesaro, Maura Faraci, Arcangelo Prete, Franco Locatelli, Andrea Pession, Marco Candela, Riccardo Masetti
BMC Medical Genomics, 2019
CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity
Riccardo Masetti, Salvatore N. Bertuccio, Andrea Pession, Franco Locatelli
British Journal of Haematology, 2019
Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities
Andrea Pession, Annalisa Lonetti, Salvatore Bertuccio, Franco Locatelli, Riccardo Masetti
Expert Opinion on Therapeutic Targets, 2019
Successes and Challenges for Diagnosis and Therapy of Acute Leukemia
Annalisa Lonetti, Ilaria Iacobucci, Riccardo Masetti
Journal of Oncology, 2019
Hepatic Tumours
Matteo Carella, Riccardo Masetti, Claudio Antonellini, Beatrice Randi, Andrea Pession
Neonatal Surgery Contemporary Strategies from Fetal Life to the First Year of Age, 2019
Wilms Tumor in Neonates
Matteo Carella, Riccardo Masetti, Claudio Antonellini, Beatrice Randi, Andrea Pession
Neonatal Surgery Contemporary Strategies from Fetal Life to the First Year of Age, 2019
Neuroblastoma in Neonates
Matteo Carella, Riccardo Masetti, Claudio Antonellini, Beatrice Randi, Andrea Pession, Mario Lima
Neonatal Surgery Contemporary Strategies from Fetal Life to the First Year of Age, 2019
Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease
Daniele Zama, Gianluca Bossù, Federico Ravaioli, Riccardo Masetti, Arcangelo Prete, Davide Festi, Andrea Pession
Pediatric Transplantation, 2019
Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients
Diana M. Byrnes, Fernando Vargas, Christopher Dermarkarian, Ryan Kahn, Deukwoo Kwon, Judith Hurley, Jonathan H. Schatz
Journal of Oncology, 2019
Seizures in children with high blood pressure
Medico E Bambino, 2019
Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
Francesco Venturelli, Riccardo Masetti, Marianna Fabi, Roberto Rondelli, Anna Martoni, Arcangelo Prete, Marco Bonvicini, Andrea Pession
Cardio Oncology, 2018
Somatic mutations activating Wiskott–Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patients
Alessandro Coppe, Leonardo Nogara, Matteo Samuele Pizzuto, Alice Cani, Simone Cesaro, Riccardo Masetti, Franco Locatelli, Geertruy te Kronnie, Giuseppe Basso, Stefania Bortoluzzi, Silvia Bresolin
Human Mutation, 2018
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups
Ursula Creutzig, Michael N. Dworzak, Martin Zimmermann, Dirk Reinhardt, Lucie Sramkova, Jan Pierre Bourquin, Henrik Hasle, Jonas Abrahamsson, Gertjan Kaspers, Mary M. van den Heuvel, Ardine M. J. Reedijk, Barbara De Moerloose, Franco Locatelli, Riccardo Masetti
Pediatric Blood and Cancer, 2017
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
Daniel B. Lipka, Tania Witte, Reka Toth, Jing Yang, Manuel Wiesenfarth, Peter Nöllke, Alexandra Fischer, David Brocks, Zuguang Gu, Jeongbin Park, Brigitte Strahm, Marcin Wlodarski, Ayami Yoshimi, Rainer Claus, Michael Lübbert, Hauke Busch, Melanie Boerries, Mark Hartmann, Maximilian Schönung, Umut Kilik, Jens Langstein, Justyna A. Wierzbinska, Caroline Pabst, Swati Garg, Albert Catalá, Barbara De Moerloose, Michael Dworzak, Henrik Hasle, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Owen Smith, Jan Stary, Marek Ussowicz, Marry M. van den Heuvel-Eibrink, Yassen Assenov, Matthias Schlesner, Charlotte Niemeyer, Christian Flotho, Christoph Plass
Nature Communications, 2017
Outcome of children with acute leukemia given HLA-haploidentical HSCT after ab T-cell and B-cell depletion
Franco Locatelli, Pietro Merli, Daria Pagliara, Giuseppina Li Pira, Michela Falco, Daniela Pende, Roberto Rondelli, Barbarella Lucarelli, Letizia Pomponia Brescia, Riccardo Masetti, Giuseppe Maria Milano, Valentina Bertaina, Mattia Algeri, Rita Maria Pinto, Luisa Strocchio, Raffaella Meazza, Lavinia Grapulin, Rupert Handgretinger, Alessandro Moretta, Alice Bertaina, Lorenzo Moretta
Blood, 2017
Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
Rita Ortolano, Federico Baronio, Riccardo Masetti, Arcangelo Prete, Alessandra Cassio, Andrea Pession
Molecular Genetics and Metabolism Reports, 2017
Central nervous system complications in children receiving chemotherapy or hematopoietic stem cell transplantation
Duccio Maria Cordelli, Riccardo Masetti, Daniele Zama, Francesco Toni, Ilaria Castelli, Emilia Ricci, Emilio Franzoni, Andrea Pession
Frontiers in Pediatrics, 2017
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol
Barbara Buldini, Frida Rizzati, Riccardo Masetti, Franca Fagioli, Giuseppe Menna, Concetta Micalizzi, Maria Caterina Putti, Carmelo Rizzari, Nicola Santoro, Marco Zecca, Silvia Disarò, Roberto Rondelli, Pietro Merli, Martina Pigazzi, Andrea Pession, Franco Locatelli, Giuseppe Basso
British Journal of Haematology, 2017
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: A report from the AIEOP-AML group
V Bisio, M Zampini, C Tregnago, E Manara, V Salsi, A Di Meglio, R Masetti, M Togni, D Di Giacomo, S Minuzzo, A Leszl, V Zappavigna, R Rondelli, C Mecucci, A Pession, F Locatelli, G Basso, M Pigazzi
Leukemia, 2017
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT
A Colecchia, G Marasco, F Ravaioli, K Kleinschmidt, R Masetti, A Prete, A Pession, D Festi
Bone Marrow Transplantation, 2017
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene
Riccardo Masetti, Salvatore Nicola Bertuccio, Annalisa Astolfi, Francesca Chiarini, Annalisa Lonetti, Valentina Indio, Matilde De Luca, Jessica Bandini, Salvatore Serravalle, Monica Franzoni, Martina Pigazzi, Alberto Maria Martelli, Giuseppe Basso, Franco Locatelli, Andrea Pession
Journal of Hematology and Oncology, 2017
Gut microbiota and hematopoietic stem cell transplantation: Where do we stand?
D Zama, E Biagi, R Masetti, P Gasperini, A Prete, M Candela, P Brigidi, A Pession
Bone Marrow Transplantation, 2017
Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group
E Manara, G Basso, M Zampini, B Buldini, C Tregnago, R Rondelli, R Masetti, V Bisio, M Frison, K Polato, G Cazzaniga, G Menna, F Fagioli, P Merli, A Biondi, A Pession, F Locatelli, M Pigazzi
Leukemia, 2017
A New Formulation of an Old Drug: A Potential New Therapy in the Management of Oral cGvHD
Luca Bertelli, Giovanni Di Nardo, Daniele Zama, Giulia Bardasi, William Morello, Riccardo Masetti, Tamara Belotti, Maria Luisa Forchielli, Arcangelo Prete, Andrea Pession
Journal of Pediatric Hematology Oncology, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: A retrospective intergroup study
Jasmijn D. E. de Rooij, Riccardo Masetti, Marry M. van den Heuvel-Eibrink, Jean-Michel Cayuela, Jan Trka, Dirk Reinhardt, Mareike Rasche, Edwin Sonneveld, Todd A. Alonzo, Maarten Fornerod, Martin Zimmermann, Martina Pigazzi, Rob Pieters, Soheil Meshinchi, C. Michel Zwaan, Franco Locatelli
Blood, 2016
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group
Silvia Bresolin, Paola De Filippi, Francesca Vendemini, Mirko D’Alia, Marco Zecca, Lueder H. Meyer, Cesare Danesino, Franco Locatelli, Riccardo Masetti, Giuseppe Basso, Geertruy te Kronnie
Oncotarget, 2016
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents
Marcin W. Wlodarski, Shinsuke Hirabayashi, Victor Pastor, Jan Starý, Henrik Hasle, Riccardo Masetti, Michael Dworzak, Markus Schmugge, Marry van den Heuvel-Eibrink, Marek Ussowicz, Barbara De Moerloose, Albert Catala, Owen P. Smith, Petr Sedlacek, Arjan C. Lankester, Marco Zecca, Victoria Bordon, Susanne Matthes-Martin, Jonas Abrahamsson, Jörn Sven Kühl, Karl-Walter Sykora, Michael H. Albert, Bartlomiej Przychodzien, Jaroslaw P. Maciejewski, Stephan Schwarz, Gudrun Göhring, Brigitte Schlegelberger, Annámaria Cseh, Peter Noellke, Ayami Yoshimi, Franco Locatelli, Irith Baumann, Brigitte Strahm, Charlotte M. Niemeyer
Blood, 2016
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia
Hetty H. Helsmoortel, Silvia Bresolin, Tim Lammens, Hélène Cavé, Peter Noellke, Aurélie Caye, Farzaneh Ghazavi, Andrica de Vries, Henrik Hasle, Veerle Labarque, Riccardo Masetti, Jan Stary, Marry M. van den Heuvel-Eibrink, Jan Philippé, Nadine Van Roy, Yves Benoit, Frank Speleman, Charlotte Niemeyer, Christian Flotho, Giuseppe Basso, Geertruy te Kronnie, Pieter Van Vlierberghe, Barbara De Moerloose
Blood, 2016
GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia
Borhane Guezguez, Mohammed Almakadi, Yannick D. Benoit, Zoya Shapovalova, Susann Rahmig, Aline Fiebig-Comyn, Fanny L. Casado, Borko Tanasijevic, Silvia Bresolin, Riccardo Masetti, Bradley W. Doble, Mickie Bhatia
Cancer Cell, 2016
Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing
Riccardo Masetti, Ilaria Castelli, Annalisa Astolfi, Salvatore Nicola Bertuccio, Valentina Indio, Marco Togni, Tamara Belotti, Salvatore Serravalle, Giuseppe Tarantino, Marco Zecca, Martina Pigazzi, Giuseppe Basso, Andrea Pession, Franco Locatelli
Oncotarget, 2016
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment
Pier Paolo Leoncini, Alice Bertaina, Dimitrios Papaioannou, Christian Flotho, Riccardo Masetti, Silvia Bresolin, Giuseppe Menna, Nicola Santoro, Marco Zecca, Giuseppe Basso, Giovanni Nigita, Dario Veneziano, Sara Pagotto, Katia D’Ovidio, Rossella Rota, Adrienne Dorrance, Carlo M. Croce, Charlotte Niemeyer, Franco Locatelli, Ramiro Garzon
Oncotarget, 2016
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial
Paola Quarello, Franca Fagioli, Giuseppe Basso, Maria C. Putti, Massimo Berger, Matteo Luciani, Carmelo Rizzari, Giuseppe Menna, Riccardo Masetti, Franco Locatelli
British Journal of Haematology, 2015
Erroneous HLA typing as a result of acquired uniparental disomy in a patient with acute lymphoblastic leukaemia in peripheral blood complete remission
Bontadini, Andrea, Iannelli, Sandra, Fruet, Fiorenza, Capelli, Simonetta, Masetti, Riccardo, et al.
Blood Transfusion, 2015
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: A retrospective international study
Hiroto Inaba, Yinmei Zhou, Oussama Abla, Souichi Adachi, Anne Auvrignon, H. Berna Beverloo, Eveline de Bont, Tai-Tsung Chang, Ursula Creutzig, Michael Dworzak, Sarah Elitzur, Alcira Fynn, Erik Forestier, Henrik Hasle, Der-Cherng Liang, Vincent Lee, Franco Locatelli, Riccardo Masetti, Barbara De Moerloose, Dirk Reinhardt, Laura Rodriguez, Nadine Van Roy, Shuhong Shen, Takashi Taga, Daisuke Tomizawa, Allen E. J. Yeoh, Martin Zimmermann, Susana C. Raimondi
Blood, 2015
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT
E Biagi, D Zama, C Nastasi, C Consolandi, J Fiori, S Rampelli, S Turroni, M Centanni, M Severgnini, C Peano, G de Bellis, G Basaglia, R Gotti, R Masetti, A Pession, P Brigidi, M Candela
Bone Marrow Transplantation, 2015
Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing
Marco Togni, Riccardo Masetti, Martina Pigazzi, Annalisa Astolfi, Daniele Zama, Valentina Indio, Salvatore Serravalle, Elena Manara, Valeria Bisio, Carmelo Rizzari, Giuseppe Basso, Andrea Pession, Franco Locatelli
Journal of Hematology and Oncology, 2015
PRES in children undergoing hematopoietic stem cell or solid organ transplantation
Riccardo Masetti, Duccio Maria Cordelli, Daniele Zama, Francesca Vendemini, Carlotta Biagi, Emilio Franzoni, Andrea Pession
Pediatrics, 2015
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: A retrospective analysis of the EWOG-MDS study group
Annamaria Cseh, Charlotte M. Niemeyer, Ayami Yoshimi, Michael Dworzak, Henrik Hasle, Marry M. van den Heuvel-Eibrink, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Ute Groß-Wieltsch, Andrea Candás, Andreas E. Kulozik, Lale Olcay, Meinolf Suttorp, Ingrid Furlan, Brigitte Strahm, Christian Flotho
Blood, 2015
Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia
Sanja Aveic, Giampietro Viola, Benedetta Accordi, Concetta Micalizzi, Nicola Santoro, Riccardo Masetti, Franco Locatelli, Giuseppe Basso, Martina Pigazzi
Experimental Hematology, 2015
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.
F Locatelli, R Masetti, R Rondelli, M Zecca, F Fagioli, A Rovelli, C Messina, E Lanino, A Bertaina, C Favre, G Giorgiani, M Ripaldi, O Ziino, G Palumbo, M Pillon, A Pession, S Rutella, A Prete, on behalf of AIEOP BMT Working Group
Bone Marrow Transplantation, 2015
Erratum: Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the AIEOP AML-2002/01 study (Bone Marrow Transplantation (2015) 15 (320))
F Locatelli, R Masetti, R Rondelli, M Zecca, F Fagioli, A Rovelli, C Messina, E Lanino, A Bertaina, C Favre, G Giorgiani, M Ripaldi, O Ziino, G Palumbo, M Pillon, A Pession, S Rutella, A Prete, on behalf of AIEOP BMT Working Group
Bone Marrow Transplantation, 2015
Gonadal tumors
Riccardo Masetti, Daniele Zama, Francesca Vendemini, Andrea Pession
Pediatric Urology Contemporary Strategies from Fetal Life to Adolescence, 2015
Acute myeloid leukemia in infants: Biology and treatment
Riccardo Masetti, Francesca Vendemini, Daniele Zama, Carlotta Biagi, Andrea Pession, Franco Locatelli
Frontiers in Pediatrics, 2015
Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation
Riccardo Masetti, Daniele Zama, Milena Urbini, Annalisa Astolfi, Virginia Libri, Francesca Vendemini, William Morello, Roberto Rondelli, Arcangelo Prete, Andrea Pession
Journal of Immunology Research, 2015
Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement
M. Pigazzi, E. Manara, B. Buldini, V. Beqiri, V. Bisio, C. Tregnago, R. Rondelli, R. Masetti, M. C. Putti, F. Fagioli, C. Rizzari, A. Pession, F. Locatelli, G. Basso
Haematologica, 2015
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
C. M. Niemeyer, M. L. Loh, A. Cseh, T. Cooper, C. C. Dvorak, R. Chan, B. Xicoy, U. Germing, S. Kojima, A. Manabe, M. Dworzak, B. De Moerloose, J. Stary, O. P. Smith, R. Masetti, A. Catala, E. Bergstraesser, M. Ussowicz, O. Fabri, A. Baruchel, H. Cave, M. Zwaan, F. Locatelli, H. Hasle, M. M. van den Heuvel-Eibrink, C. Flotho, A. Yoshimi
Haematologica, 2015
Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children
D Zama, R Masetti, D M Cordelli, F Vendemini, L Giordano, G Milito, E Franzoni, F Porta, A Prete, R Rondelli, A Pession
Bone Marrow Transplantation, 2014
Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea
Daniele Zama, Ilaria Cocchi, Riccardo Masetti, Fernando Specchia, Patrizia Alvisi, Eleonora Gambineri, Mario Lima, Andrea Pession
Italian Journal of Pediatrics, 2014
Juvenile arthritis after haematopoietic stem cell transplantation
E Tronconi, A Miniaci, A Prete, R Masetti, A Pession
Bone Marrow Transplantation, 2014
Inflammatory disease of the central nervous system induced by anti-GD2 monoclonal antibody in a patient with high risk neuroblastoma
Daniele Zama, William Morello, Riccardo Masetti, Duccio Maria Cordelli, Erika Massaccesi, Arcangelo Prete, Andrea Pession
Pediatric Blood and Cancer, 2014
Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children
R. Masetti, R. Rondelli, F. Fagioli, A. Mastronuzzi, P. Pierani, M. Togni, G. Menna, M. Pigazzi, M. C. Putti, G. Basso, A. Pession, F. Locatelli
Haematologica, 2014
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
Alice Bertaina, Pietro Merli, Sergio Rutella, Daria Pagliara, Maria Ester Bernardo, Riccardo Masetti, Daniela Pende, Michela Falco, Rupert Handgretinger, Francesca Moretta, Barbarella Lucarelli, Letizia P. Brescia, Giuseppina Li Pira, Manuela Testi, Caterina Cancrini, Nabil Kabbara, Rita Carsetti, Andrea Finocchi, Alessandro Moretta, Lorenzo Moretta, Franco Locatelli
Blood, 2014
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia
Elena Manara, Emma Baron, Claudia Tregnago, Sanja Aveic, Valeria Bisio, Silvia Bresolin, Riccardo Masetti, Franco Locatelli, Giuseppe Basso, Martina Pigazzi
Blood, 2014
T(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: An international study of 62 patients
J. D. Sandahl, E. A. Coenen, E. Forestier, J. Harbott, B. Johansson, G. Kerndrup, S. Adachi, A. Auvrignon, H. B. Beverloo, J.-M. Cayuela, L. Chilton, M. Fornerod, V. de Haas, C. J. Harrison, H. Inaba, G. J. L. Kaspers, D.-C. Liang, F. Locatelli, R. Masetti, C. Perot, S. C. Raimondi, K. Reinhardt, D. Tomizawa, N. von Neuhoff, M. Zecca, C. M. Zwaan, M. M. van den Heuvel-Eibrink, H. Hasle
Haematologica, 2014
Etiology, characteristics and outcome of seizures after pediatric hematopoietic stem cell transplantation
Duccio Maria Cordelli, Riccardo Masetti, Daniele Zama, Daniela Gueraldi, Roberto Rondelli, Carlo Cottone, Arcangelo Prete, Andrea Pession, Emilio Franzoni
Seizure, 2014
Left ventricular mass and cardiac function in a population of children with chronic kidney disease
Francesca Mencarelli, Marianna Fabi, Valentina Corazzi, Anke Doyon, Riccardo Masetti, Simone Bonetti, Laura Castiglioni, Andrea Pession, Giovanni Montini
Pediatric Nephrology, 2014
Life-threatening complications of posterior reversible encephalopathy syndrome in children
Duccio M. Cordelli, Riccardo Masetti, Emilia Ricci, Francesco Toni, Daniele Zama, Monica Maffei, Andrea Gentili, Antonia Parmeggiani, Andrea Pession, Emilio Franzoni
European Journal of Paediatric Neurology, 2014
Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del(5q) reveals RUNX1-USP42 and PRDM16-SKI fusion transcripts
Riccardo Masetti, Marco Togni, Annalisa Astolfi, Martina Pigazzi, Valentina Indio, Beatrice Rivalta, Elena Manara, Sergio Rutella, Giuseppe Basso, Andrea Pession, Franco Locatelli
British Journal of Haematology, 2014
Two cases of abdominal pain in children with mesenteric lymphadenitis due to yersinia pseudotuberculosis infection
Luca Bertelli, Riccardo Masetti, Giulia Bardasi, Michela Maretti, Tommaso Gargano, Ilaria Corsini, Fraia Melchionda, Davide Tassinari, Salvatore Cazzato, Mario Lima, Andrea Pession
Journal of Pediatrics, 2014
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: Screening and prognostic impact of c-KIT mutations
E Manara, V Bisio, R Masetti, V Beqiri, R Rondelli, G Menna, C Micalizzi, N Santoro, F Locatelli, G Basso, M Pigazzi
Leukemia, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
Valentina Folgiero, Bianca M. Goffredo, Perla Filippini, Riccardo Masetti, Giuseppina Bonanno, Roberta Caruso, Valentina Bertaina, Angela Mastronuzzi, Stefania Gaspari, Marco Zecca, Giovanni F. Torelli, Anna M. Testi, Andrea Pession, Franco Locatelli, Sergio Rutella
Oncotarget, 2014
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
Annalisa Astolfi, Francesca Vendemini, Milena Urbini, Fraia Melchionda, Riccardo Masetti, Monica Franzoni, Virginia Libri, Salvatore Serravalle, Marco Togni, Giuseppina Paone, Luca Montemurro, Daniela Bressanin, Francesca Chiarini, Alberto M. Martelli, Roberto Tonelli, Andrea Pession
Oncotarget, 2014
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation
Riccardo Masetti, Daniele Zama, Pietro Gasperini, William Morello, Arcangelo Prete, Antonio Colecchia, Davide Festi, Andrea Pession
Pediatric Transplantation, 2013
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia
Andrea Pession, Riccardo Masetti, Carmelo Rizzari, Maria Caterina Putti, Fiorina Casale, Franca Fagioli, Matteo Luciani, Luca Lo Nigro, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Anna Maria Testi, Marco Zecca, Andrea Biondi, Martina Pigazzi, Sergio Rutella, Roberto Rondelli, Giuseppe Basso, Franco Locatelli
Blood, 2013
Leucemie mieloidi acute del bambino: Solo chemioterapia per la cura?
Pediatric Reports, 2013
CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype
Riccardo Masetti, Martina Pigazzi, Marco Togni, Annalisa Astolfi, Valentina Indio, Elena Manara, Rita Casadio, Andrea Pession, Giuseppe Basso, Franco Locatelli
Blood, 2013
Recurrent pneumothorax, pneumomediastinum, and subcutaneous emphysema in late-onset noninfectious pulmonary complications (LONIPCs) after hematopoietic stem cell transplantation
Riccardo Masetti, Daniele Zama, Francesca Vendemini, Arcangelo Prete, Andrea Gentili, Mario Lima, Andrea Pession
Journal of Pediatric Hematology Oncology, 2013
MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation
M. Pigazzi, E. Manara, S. Bresolin, C. Tregnago, A. Beghin, E. Baron, E. Giarin, E.-C. Cho, R. Masetti, D. S. Rao, K. M. Sakamoto, G. Basso
Haematologica, 2013
Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients
Daniele Zama, Riccardo Masetti, Francesca Vendemini, Ferruccio Di Donato, Alessandra Morelli, Arcangelo Prete, Andrea Pession
Pediatric Transplantation, 2013
Benign hepatic nodular lesions after treatment for childhood cancer
R. Masetti, A. Colecchia, R. Rondelli, A. Martoni, F. Vendemini, C. Biagi, A. Prete, D. Festi, M. Lima, A. Pession
Journal of Pediatric Gastroenterology and Nutrition, 2013
Lung tumors
Riccardo Masetti, Luca Bertelli, Daniele Zama, Tamara Belotti, Andrea Pession
Pediatric Thoracic Surgery, 2013
Tumors of the chest wall
Riccardo Masetti, Daniele Zama, Luca Bertelli, Tamara Belotti, Andrea Pession
Pediatric Thoracic Surgery, 2013
Anterior mediastinal tumors
Riccardo Masetti, Tamara Belotti, Luca Bertelli, Daniele Zama, Andrea Pession
Pediatric Thoracic Surgery, 2013
Perfluoroalkyl substances in human milk: A first survey in Italy
Andrea Barbarossa, Riccardo Masetti, Teresa Gazzotti, Daniele Zama, Annalisa Astolfi, Bruno Veyrand, Andrea Pession, Giampiero Pagliuca
Environment International, 2013
DHH-RHEBL1 fusion transcript: A novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
Riccardo Masetti, Marco Togni, Annalisa Astolfi, Martina Pigazzi, Elena Manara, Valentina Indio, Carmelo Rizzari, Sergio Rutella, Giuseppe Basso, Andrea Pession, Franco Locatelli
Oncotarget, 2013
Endothelial dysfunction: New therapeutic strategies
Pediatric Reports, 2012
Screening of novel genetic aberrations in pediatric acute myeloid leukemia: A report from the AIEOP AML-2002 study group
Martina Pigazzi, Elena Manara, Valeria Bisio, Sanja Aveic, Riccardo Masetti, Giuseppe Menna, Marco Zecca, Andrea Pession, Franco Locatelli, Giuseppe Basso
Blood, 2012
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia
Riccardo Masetti, Francesca Vendemini, Daniele Zama, Carlotta Biagi, Pietro Gasperini, Andrea Pession
Expert Review of Anticancer Therapy, 2012
Retinoids in pediatric onco-hematology: The model of acute promyelocytic leukemia and neuroblastoma
Riccardo Masetti, Carlotta Biagi, Daniele Zama, Francesca Vendemini, Anna Martoni, William Morello, Pietro Gasperini, Andrea Pession
Advances in Therapy, 2012
Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: Is this a valid option?
Andrea Pession, Daniele Zama, Riccardo Masetti, Pietro Gasperini, Arcangelo Prete
Pediatric Transplantation, 2012
Autoimmune polyglandular syndrome type III after haploidentical hematopoietic stem cell transplantation in a child with acute myeloid leukemia
Katharina Kleinschmidt, Anna Martoni, Riccardo Masetti, Alessandra Cassio, Arcangelo Prete, Andrea Pession
Pediatric Blood and Cancer, 2012
Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia-Positive Acute Lymphoblastic Leukemia in Children and Adolescents: A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
Franca Fagioli, Marco Zecca, Carla Rognoni, Edoardo Lanino, Adriana Balduzzi, Massimo Berger, Chiara Messina, Claudio Favre, Marco Rabusin, Luca Lo Nigro, Riccardo Masetti, Arcangelo Prete, Franco Locatelli
Biology of Blood and Marrow Transplantation, 2012
Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation
Duccio Maria Cordelli, Riccardo Masetti, Bruno Bernardi, Giulia Barcia, Valentina Gentile, Carlotta Biagi, Arcangelo Prete, Andrea Pession, Emilio Franzoni
Pediatric Blood and Cancer, 2012
FLAG-liposomal doxorubicin (myocet) regimen for refractory or relapsed acute leukemia pediatric patients
Paola Quarello, Massimo Berger, Elisa Rivetti, Chiara Galletto, Riccardo Masetti, Rosaria Manicone, Elena Barisone, Andrea Pession, Franca Fagioli
Journal of Pediatric Hematology Oncology, 2012
Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia
Martina Pigazzi, Riccardo Masetti, Francesco Martinolli, Elena Manara, Alessandra Beghin, Roberto Rondelli, Franco Locatelli, Franca Fagioli, Andrea Pession, Giuseppe Basso
Blood, 2012
Unbalance of intestinal microbiota in atopic children.
Marco Candela, Simone Rampelli, Silvia Turroni, Marco Severgnini, Clarissa Consolandi, Gianluca De Bellis, Riccardo Masetti, Giampaolo Ricci, Andrea Pession, Patrizia Brigidi
BMC Microbiology, 2012
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission
Giorgio Dini, Marco Zecca, Adriana Balduzzi, Chiara Messina, Riccardo Masetti, Franca Fagioli, Claudio Favre, Marco Rabusin, Fulvio Porta, Erika Biral, Mimmo Ripaldi, Anna Paola Iori, Carla Rognoni, Arcangelo Prete, Franco Locatelli
Blood, 2011
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: An Italian study
M. Paganin, M. Pigazzi, S. Bresolin, R. Masetti, F. Fagioli, S. Chiaretti, G. Cazzaniga, F. Locatelli, A. Pession, G. te Kronnie, G. Basso
Haematologica, 2011
Emerging targeted therapies for pediatric acute myeloid leukemia
Riccardo Masetti, Katharina Kleinschmidt, Carlotta Biagi, Andrea Pession
Recent Patents on Anti Cancer Drug Discovery, 2011
Erratum: Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: A prospective randomized study (Transplantation (2011) 92:3 (e14))
Transplantation, 2011
Granulocytic sarcoma of the knee and the Spine as aleukemic relapse of acute myeloid leukemia in a child
Riccardo Masetti, Pietro Gasperini, Arcangelo Prete, Andrea Pession
Journal of Pediatric Hematology Oncology, 2011
Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an italian expert panel
Andrea Pession, Riccardo Masetti, Gianluca Gaidano, Patrizia Tosi, Giovanni Rosti, Massimo Aglietta, Giorgina Specchia, Fulvio Porta, Fabrizio Pane
Advances in Therapy, 2011
Organizing pneumonia primed by high-dose chemotherapy and lung irradiation: Two pediatric cases
Riccardo Masetti, Salvatore Cazzato, Arcangelo Prete, Roberto Rondelli, Anna Olga Di Vincenzo, Andrea Pession
Journal of Pediatric Hematology Oncology, 2011
Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: A prospective randomized study
Cornelio Uderzo, Paola Rebora, Emanuela Marrocco, Stefania Varotto, Francesca Cichello, Maurizio Bonetti, Natalia Maximova, Davide Zanon, Franca Fagioli, Francesca Nesi, Roberto Masetti, Attilio Rovelli, Roberto Rondelli, Maria Grazia Valsecchi, Simone Cesaro
Transplantation, 2011
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: Is hematopoietic stem cell transplantation a risk factor?
Riccardo Masetti, Carlotta Biagi, Katharina Kleinschmidt, Arcangelo Prete, Federico Baronio, Antonio Colecchia, Davide Festi, Andrea Pession
European Journal of Pediatrics, 2011
The role of HDACs inhibitors in childhood and adolescence acute leukemias
Riccardo Masetti, Salvatore Serravalle, Carlotta Biagi, Andrea Pession
Journal of Biomedicine and Biotechnology, 2011
HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors
Andrea Pession, Riccardo Masetti, Corinne Di Leo, Monica Franzoni, Arcangelo Prete
Pediatric Reports, 2011
Low prevalence of IDH1 gene mutation in childhood AML in Italy
M Pigazzi, G Ferrari, R Masetti, B Falini, F Martinolli, G Basso, A Biondi, A Pession, G Cazzaniga
Leukemia, 2011
MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: An AIEOP study
M Pigazzi, R Masetti, S Bresolin, A Beghin, A Di Meglio, S Gelain, L Trentin, E Baron, M Giordan, A Zangrando, B Buldini, A Leszl, M C Putti, C Rizzari, F Locatelli, A Pession, G Te Kronnie, G Basso
Leukemia, 2011
A novel specific signature of pediatric MOZ-CBP acute myeloid leukemia
Salvatore Serravalle, Fraia Melchionda, Annalisa Astolfi, Virginia Libri, Riccardo Masetti, Andrea Pession
Leukemia Research, 2010
Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib
C Biagi, A Astolfi, R Masetti, S Serravalle, M Franzoni, F Chiarini, F Melchionda, A Pession
Leukemia, 2010
Pediatric T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma therapy
Haematologica Meeting Reports, 2009
First-line treatment of acute lymphoblastic leukemia with pegasparaginase
Andrea Pession
Biologics Targets and Therapy, 2009
How to write a cooperative protocol of diagnosis and therapy: The AIEOP LAM 2002/01 protocol model
Haematologica Meeting Reports, 2008
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype
Giovanni Cazzaniga, Maria Grazia Dell'Oro, Cristina Mecucci, Emanuela Giarin, Riccardo Masetti, Vincenzo Rossi, Franco Locatelli, Massimo F. Martelli, Giuseppe Basso, Andrea Pession, Andrea Biondi, Brunangelo Falini
Blood, 2005
Somatic PTPN11 mutations in childhood acute myeloid leukaemia
Marco Tartaglia, Simone Martinelli, Ivano Iavarone, Giovanni Cazzaniga, Monica Spinelli, Emanuela Giarin, Valentina Petrangeli, Claudio Carta, Riccardo Masetti, Maurizio Aricò, Franco Locatelli, Giuseppe Basso, Mariella Sorcini, Andrea Pession, Andrea Biondi
British Journal of Haematology, 2005

RICCARDO MASETTI

RESEARCH INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS